#Coronavirus Disease Research #References (by AMEDEO.com, June 22 ’24)


  1. Correction: Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19.
    Ann Intern Med. 2024 Jun 18. doi: 10.7326/ANNALS-24-00699.
    PubMed        


    Antiviral Res
  2. DICKEY TH, Salinas ND, Patel P, Orr-Gonzalez S, et al
    RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination.
    Antiviral Res. 2024 Jun 18:105937. doi: 10.1016/j.antiviral.2024.105937.
    PubMed         Abstract available


    BMJ
  3. MORGAN J
    “I wasn’t alone after all”-how modelling vulnerability can support staff wellbeing.
    BMJ. 2024;385:q1313.
    PubMed        
  4. ALKHALDI M
    Call to boost the profile of the Middle East and north Africa region in global health.
    BMJ. 2024;385:q1272.
    PubMed        
  5. LIMB M
    Election watch: How credible are the main parties’ pledges on the NHS?
    BMJ. 2024;385:q1320.
    PubMed        
  6. OXTOBY K
    Why I . . . go adventure sailing.
    BMJ. 2024;385:q1292.
    PubMed        
  7. IRWIN EM
    Knock, knock. Who’s there? It’s the senior house officers trying to come back . .
    BMJ. 2024;385:q1343.
    PubMed        
  8. POLKINGHORN A
    Thank you for waiting.
    BMJ. 2024;385:q1295.
    PubMed        
  9. FEINMANN J
    Analysis reveals global post-covid surge in infectious diseases.
    BMJ. 2024;385:q1348.
    PubMed        
  10. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    PubMed        
  11. O’DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    PubMed        
  12. OLIVER D
    David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    PubMed        
  13. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    PubMed        
  14. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    PubMed        
  15. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    PubMed        
  16. FEINMANN J
    GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    PubMed        
  17. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    PubMed        
  18. IACOBUCCI G
    Junior doctors offer prime minister “final chance” to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    PubMed        


    Int J Infect Dis
  19. FARMER G, Sikdar KC, Lo T, Conly J, et al
    Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity matched retrospective cohort study of a pan-provincial program in Alberta, Canada.
    Int J Infect Dis. 2024 Jun 14:107136. doi: 10.1016/j.ijid.2024.107136.
    PubMed         Abstract available
  20. HUIBERTS AJ, van den Hof S, Knol MJ
    Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.
    Int J Infect Dis. 2024 Jun 18:107127. doi: 10.1016/j.ijid.2024.107127.
    PubMed        


    J Infect
  21. MIKOLAJCZYK R, Diexer S, Klee B, Pfrommer L, et al
    Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).
    J Infect. 2024 Jun 17:106206. doi: 10.1016/j.jinf.2024.106206.
    PubMed         Abstract available
  22. KAJIHARA T, Yahara K, Kamigaki T, Hirabayashi A, et al
    Effects of coronavirus disease 2019 on the spread of respiratory-transmitted human-to-human bacteria.
    J Infect. 2024 Jun 17:106201. doi: 10.1016/j.jinf.2024.106201.
    PubMed         Abstract available
  23. LIU B, Xu L, Ma Y, Wang H, et al
    Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.
    J Infect. 2024 Jun 18:106209. doi: 10.1016/j.jinf.2024.106209.
    PubMed        


    J Med Virol
  24. BLANGY-LETHEULE A, Vergnaud A, Dupas T, Habert D, et al
    Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit.
    J Med Virol. 2024;96:e29756.
    PubMed         Abstract available
  25. ALMANZAR G, Koosha K, Vogt T, Stein A, et al
    Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2024;96:e29739.
    PubMed         Abstract available
  26. TANG Y, Zou X, Liu P, Dai Y, et al
    Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID.
    J Med Virol. 2024;96:e29757.
    PubMed         Abstract available
  27. KARBIENER M, Kindle G, Meyts I, Seppanen MRJ, et al
    Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
    J Med Virol. 2024;96:e29738.
    PubMed         Abstract available
  28. ZHU W, Gu L
    Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023-2024 season in Beijing showing increased population susceptibility.
    J Med Virol. 2024;96:e29751.
    PubMed         Abstract available


    J Virol
  29. CHEN Z, Cui Q, Ran Y, Achi JG, et al
    A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
    PubMed         Abstract available
  30. STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
    Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
    J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
    PubMed         Abstract available
  31. PAN R, Li P, Meyerholz DK, Perlman S, et al
    Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
    J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
    PubMed         Abstract available


    JAMA
  32. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed        
  33. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        
  34. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed        


    Lancet
  35. ZAROCOSTAS J
    Mental health in emergencies requires “a major rethink”.
    Lancet. 2024;403:2582.
    PubMed        
  36. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed        
  37. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed        
  38. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed        
  39. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        
  40. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed        


    N Engl J Med
  41. SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al
    Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177.
    PubMed         Abstract available


    Nature
  42. LINDEBOOM RGH, Worlock KB, Dratva LM, Yoshida M, et al
    Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
    Nature. 2024 Jun 19. doi: 10.1038/s41586-024-07575.
    PubMed         Abstract available
  43. ISRAELOW B, Iwasaki A
    First encounter with SARS-CoV-2: immune portraits of COVID susceptibility.
    Nature. 2024 Jun 19. doi: 10.1038/d41586-024-01644.
    PubMed        
  44. NURSE P
    We can make the UK a science superpower – with a radical political manifesto.
    Nature. 2024;630:532.
    PubMed        
  45. RIVA L, Yuan S, Yin X, Martin-Sancho L, et al
    Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
    Nature. 2024 Jun 18. doi: 10.1038/s41586-024-07659.
    PubMed        
  46. KULKARNI S
    AI and Euro 2024: VAR is shaking up football – and it’s not going away.
    Nature. 2024;630:538-539.
    PubMed        
  47. CASTELVECCHI D
    CERN’s $17-billion supercollider in question as top funder criticizes cost.
    Nature. 2024;630:539-540.
    PubMed        

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO.com, June 22 ’24)

  1. AMERATUNGA R, Jordan A, Lehnert K, Leung E, et al
    SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
    Antiviral Res. 2024 Apr 25:105894. doi: 10.1016/j.antiviral.2024.105894.
    PubMed         Abstract available
  2. SUN Y, Wagatsuma K, Saito R, Sato I, et al
    Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012-2013 and 2019-2020 influenza seasons.
    Antiviral Res. 2024 Jun 17:105938. doi: 10.1016/j.antiviral.2024.105938.
    PubMed         Abstract available
  3. LE UNP, Chang YJ, Lu CH, Chen Y, et al
    Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
    Antiviral Res. 2024;227:105920.
    PubMed         Abstract available
  4. LIANG Y, Xiao W, Peng Y, Zhang S, et al
    Development of Nanoparticle Vaccines Utilizing Designed Fc-Binding Homo-oligomers and RBD-Fc of SARS-CoV-2.
    Antiviral Res. 2024 May 21:105917. doi: 10.1016/j.antiviral.2024.105917.
    PubMed         Abstract available
  5. BONNEUX B, Shareef A, Tcherniuk S, Anson B, et al
    JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase.
    Antiviral Res. 2024;227:105907.
    PubMed         Abstract available
  6. HUANG J, Wang W, Li H, Bai Y, et al
    Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.
    Antiviral Res. 2024;227:105905.
    PubMed         Abstract available
  7. PANDEY K, Acharya A, Pal D, Jain P, et al
    SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
    Antiviral Res. 2024;227:105904.
    PubMed         Abstract available
  8. SALGADO-BENVINDO C, Tas A, Zevenhoven-Dobbe JC, van der Meer Y, et al
    Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: a versatile and practical infection model for antiviral research and beyond.
    Antiviral Res. 2024 May 7:105903. doi: 10.1016/j.antiviral.2024.105903.
    PubMed         Abstract available


    Biochemistry (Mosc)
  9. AFRIDONOVA ZE, Toptygina AP, Mikhaylov IS
    Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins.
    Biochemistry (Mosc). 2024;89:872-882.
    PubMed         Abstract available
  10. ASTAKHOVA EA, Morozov AA, Vavilova JD, Filatov AV, et al
    Antigenic Cartography of SARS-CoV-2.
    Biochemistry (Mosc). 2024;89:862-871.
    PubMed         Abstract available


    BMC Pediatr
  11. UPPALA R, Seenoikhao N, Sitthikarnkha P, Niamsanit S, et al
    Clinical characteristics and prognostic marker for hospitalization in children with influenza infection in an emergency setting.
    BMC Pediatr. 2024;24:399.
    PubMed         Abstract available


    BMJ
  12. MORGAN J
    “I wasn’t alone after all”-how modelling vulnerability can support staff wellbeing.
    BMJ. 2024;385:q1313.
    PubMed        
  13. ALKHALDI M
    Call to boost the profile of the Middle East and north Africa region in global health.
    BMJ. 2024;385:q1272.
    PubMed        
  14. LIMB M
    Election watch: How credible are the main parties’ pledges on the NHS?
    BMJ. 2024;385:q1320.
    PubMed        
  15. OXTOBY K
    Why I . . . go adventure sailing.
    BMJ. 2024;385:q1292.
    PubMed        
  16. IRWIN EM
    Knock, knock. Who’s there? It’s the senior house officers trying to come back . .
    BMJ. 2024;385:q1343.
    PubMed        
  17. POLKINGHORN A
    Thank you for waiting.
    BMJ. 2024;385:q1295.
    PubMed        
  18. FEINMANN J
    Analysis reveals global post-covid surge in infectious diseases.
    BMJ. 2024;385:q1348.
    PubMed        
  19. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    PubMed        
  20. O’DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    PubMed        
  21. OLIVER D
    David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    PubMed        
  22. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    PubMed        
  23. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    PubMed        
  24. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    PubMed        
  25. FEINMANN J
    GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    PubMed        
  26. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    PubMed        
  27. NOLAN T
    Avian flu virus in raw milk … and other research.
    BMJ. 2024;385:q1331.
    PubMed        
  28. IACOBUCCI G
    Junior doctors offer prime minister “final chance” to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    PubMed        


    Drug Saf
  29. GORDILLO-MARANON M, Candore G, Hedenmalm K, Browne K, et al
    Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination.
    Drug Saf. 2024;47:607-615.
    PubMed         Abstract available


    J Clin Microbiol
  30. YU S-H, Kim K-J, Lee C-C, Puebla YP, et al
    Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs.
    J Clin Microbiol. 2024 Jun 18:e0020724. doi: 10.1128/jcm.00207.
    PubMed         Abstract available


    J Infect
  31. HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
    J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
    PubMed        
  32. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
    Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
    J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
    PubMed         Abstract available
  33. AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
    Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
    J Infect. 2024;89:106179.
    PubMed        
  34. YANG X, Li X, Qiu S, Liu C, et al
    Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data.
    J Infect. 2024 May 14:106183. doi: 10.1016/j.jinf.2024.106183.
    PubMed         Abstract available
  35. MOKRANI D, Le Hingrat Q, Thy M, Choquet C, et al
    Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France.
    J Infect. 2024;89:106180.
    PubMed         Abstract available
  36. HAN B, Li XM, Li R, Ning W, et al
    Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
    J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
    PubMed        
  37. ZHAI K, Dong J, Zeng J, Cheng P, et al
    Global Antigenic Landscape and Vaccine Recommendation Strategy for Low Pathogenic Avian Influenza A(H9N2) Viruses.
    J Infect. 2024 Jun 18:106199. doi: 10.1016/j.jinf.2024.106199.
    PubMed         Abstract available


    J Virol Methods
  38. MORECCHIATO F, Coppi M, Niccolai C, Antonelli A, et al
    Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples.
    J Virol Methods. 2024;328:114956.
    PubMed         Abstract available


    JAMA
  39. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed        
  40. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        


    Lancet
  41. ZAROCOSTAS J
    Mental health in emergencies requires “a major rethink”.
    Lancet. 2024;403:2582.
    PubMed        
  42. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed        
  43. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        
  44. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed        
  45. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed        
  46. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed        


    N Engl J Med

  47. Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed        


    PLoS Comput Biol
  48. ROJAS CHAVEZ RA, Fili M, Han C, Rahman SA, et al
    Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics.
    PLoS Comput Biol. 2024;20:e1012215.
    PubMed         Abstract available


    PLoS One
  49. LIMA HS, Tupinambas U, Guimaraes FG
    Estimating time-varying epidemiological parameters and underreporting of Covid-19 cases in Brazil using a mathematical model with fuzzy transitions between epidemic periods.
    PLoS One. 2024;19:e0305522.
    PubMed         Abstract available
  50. KOLIVAND P, Saberian P, Arabloo J, Behzadifar M, et al
    Impact of COVID-19 pandemic on road traffic injuries in Iran: An interrupted time-series analysis.
    PLoS One. 2024;19:e0305081.
    PubMed         Abstract available
  51. POTTECHER J, Raffi F, Jandrot-Perrus M, Binay S, et al
    Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
    PLoS One. 2024;19:e0302897.
    PubMed         Abstract available
  52. GORGELS KMF, Mujakovic S, Stallenberg E, Hackert VH, et al
    Implementation and effectiveness of non-pharmaceutical interventions, including mask mandates and ventilation, on SARS-CoV-2 transmission (alpha variant) in primary schools in the Netherlands.
    PLoS One. 2024;19:e0305195.
    PubMed         Abstract available
  53. WANG S, Ren J, Guo X
    A high-accuracy lightweight network model for X-ray image diagnosis: A case study of COVID detection.
    PLoS One. 2024;19:e0303049.
    PubMed         Abstract available
  54. LENNOX C, Duncan-Zaleski M, Nasim S, Shirley O, et al
    The impact of the COVID-19 pandemic for children in custody: An analysis of inspection reports.
    PLoS One. 2024;19:e0304862.
    PubMed         Abstract available
  55. REED DS, McElroy AK, Barbeau DJ, McMillen CM, et al
    No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
    PLoS One. 2024;19:e0290909.
    PubMed         Abstract available
  56. ZAIDAN M, Puebla Neira D, Polychronopoulou E, Yong-Fang K, et al
    Healthcare utilization 9 months pre- and post- COVID-19 hospitalization among patients discharged alive.
    PLoS One. 2024;19:e0303509.
    PubMed         Abstract available
  57. CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
    Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    PLoS One. 2024;19:e0303303.
    PubMed         Abstract available
  58. DONAGHY R, Shinskey J, Tsakiris M
    Maternal interoceptive focus is associated with greater reported engagement in mother-infant stroking and rocking.
    PLoS One. 2024;19:e0302791.
    PubMed         Abstract available
  59. SETO E
    At freedom’s edge: Belief in free will during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303291.
    PubMed         Abstract available
  60. SANDBERG L, Bostrom AM, Hagstromer M, Lindgren C, et al
    Feasibility of the “Preventing functional decline in acutely hospitalized older patients (PREV_FUNC)” study-A three-armed randomized controlled pilot trial.
    PLoS One. 2024;19:e0304570.
    PubMed         Abstract available
  61. ZEBALLOS D, Magno L, Aranha Rossi T, Soares F, et al
    Performance of two rapid antigen tests against SARS-CoV-2 in neighborhoods of socioeconomic vulnerability from a middle-income country.
    PLoS One. 2024;19:e0298579.
    PubMed         Abstract available
  62. SHENEAMER AM, Halawi MH, Al-Qahtani MH
    A hybrid human recognition framework using machine learning and deep neural networks.
    PLoS One. 2024;19:e0300614.
    PubMed         Abstract available
  63. SCHOULTZ M, Mcgrogan C, Carolan C, Macaden L, et al
    Exploring barriers to care home research recruitment during the COVID-19 pandemic: The influence of social media recruitment posts and public sentiment.
    PLoS One. 2024;19:e0303609.
    PubMed         Abstract available
  64. GROVER EN, Buchwald AG, Ghosh D, Carlton EJ, et al
    Does behavior mediate the effect of weather on SARS-CoV-2 transmission? evidence from cell-phone data.
    PLoS One. 2024;19:e0305323.
    PubMed         Abstract available
  65. BASA M, De Vries J, McDonagh D, Comiskey C, et al
    The impact of COVID-19 on non-communicable disease patients in sub-Saharan African countries: A systematic review.
    PLoS One. 2024;19:e0293376.
    PubMed         Abstract available
  66. CHAMPREDON D, Papst I, Yusuf W
    ern: An [Formula: see text] package to estimate the effective reproduction number using clinical and wastewater surveillance data.
    PLoS One. 2024;19:e0305550.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  67. KIM H, Park HH, Kim HN, Seo D, et al
    The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2319322121.
    PubMed         Abstract available
  68. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed         Abstract available


    Vaccine
  69. CHENG TM, Chen YS, Wei KC, Chang YC, et al
    Assessment of the herpes zoster risk among renal transplant recipients administered the influenza vaccine.
    Vaccine. 2024 Jun 18:S0264-410X(24)00716-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  70. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    PubMed         Abstract available


    Virus Res
  71. RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
    Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
    Virus Res. 2024;347:199415.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO.com, June 15 2024)


  1. June 15 Highlight.
    Am J Respir Crit Care Med. 2024;209:xl-xlii.
    PubMed        
  2. FEYS S, Cardinali-Benigni M, Lauwers HM, Jacobs C, et al
    Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.
    Am J Respir Crit Care Med. 2024 Jun 12. doi: 10.1164/rccm.202401-0145.
    PubMed         Abstract available
  3. SNYDER ME, Kitsios GD
    Lung Transplant Outcomes Keep BUGging us: Acute Cellular Rejection and the Lung Microbiome.
    Am J Respir Crit Care Med. 2024;209:1423-1425.
    PubMed        
  4. WOZNIAK H, Doufle G, Hamilton M, Santangelo E, et al
    Behind the Mask of Intensive Care Unit Healthcare Workers.
    Am J Respir Crit Care Med. 2024 Mar 14. doi: 10.1164/rccm.202402-0350.
    PubMed        


    Ann Intern Med
  5. DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al
    COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956.
    PubMed         Abstract available


    BMJ
  6. SMITH C
    Infected blood inquiry: justice will only be delivered when all the recommendations are acted upon.
    BMJ. 2024;385:q1256.
    PubMed        
  7. VIZE R
    What are the early election promises on health?
    BMJ. 2024;385:q1258.
    PubMed        
  8. DEAN E
    Why I . . . make free flight aircraft.
    BMJ. 2024;385:q1157.
    PubMed        
  9. KMIETOWICZ Z
    Sixty seconds on . . . flying.
    BMJ. 2024;385:q1266.
    PubMed        
  10. TORJESEN I
    Hospital doctors in Wales to vote on enhanced pay deal for 2023-24.
    BMJ. 2024;385:q1273.
    PubMed        
  11. MAHASE E
    RCP president is asked to resign over handling of physician associates row.
    BMJ. 2024;385:q1291.
    PubMed        
  12. LAL N
    Study on adverse effects following Covaxin stirs heated debate in India.
    BMJ. 2024;385:q1300.
    PubMed        
  13. IACOBUCCI G
    Tories pledge to slash number of NHS managers to fund health spending.
    BMJ. 2024;385:q1297.
    PubMed        
  14. SADGROVE NEE STACEY C
    Help create an opportunity to learn together.
    BMJ. 2024;385:q868.
    PubMed        
  15. SHEPHERD A
    Striking doctors rally in Stormont.
    BMJ. 2024;385:q1280.
    PubMed        
  16. RIMMER A
    Four year medical degree set to launch in 2026, says NHS England.
    BMJ. 2024;385:q1312.
    PubMed        

  17. Seven days in medicine: 5-11 June 2024.
    BMJ. 2024;385:q1278.
    PubMed        
  18. KMIETOWICZ Z
    Labour vows to “fix NHS again” after Tories leave it “broken”.
    BMJ. 2024;385:q1315.
    PubMed        


    Clin Infect Dis
  19. DIAMOND C
    The Belt Parkway.
    Clin Infect Dis. 2024;78:1399-1400.
    PubMed        
  20. FOWLER VG JR, Durack DT, Suty-Selton C, Miro JM, et al
    Reply to Author.
    Clin Infect Dis. 2024;78:1779.
    PubMed        
  21. FUNDERBURG NT, Shive CL, Lederman MM
    Reply to Chen et al.
    Clin Infect Dis. 2024;78:1776-1777.
    PubMed        
  22. EPSTEIN L
    An Ounce of Prevention Is Worth a Pound of Cure: The LEAP Fellowship.
    Clin Infect Dis. 2024;78:1542-1543.
    PubMed        
  23. ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
    A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US
    Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
    PubMed         Abstract available
  24. YAN L, Bui D, Li Y, Rajeevan N, et al
    Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation.
    Clin Infect Dis. 2024 Jun 12:ciae202. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis
  25. ALVAREZ-HERNANDEZ G, Rivera-Rosas CN, Calleja-Lopez JRT, McCormick DW, et al
    Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico.
    Emerg Infect Dis. 2024;30.
    PubMed         Abstract available


    J Med Virol
  26. KIM H, Kyung S, Park J, Lee H, et al
    Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK.
    J Med Virol. 2024;96:e29740.
    PubMed         Abstract available
  27. AGUILAR R, Jimenez A, Santano R, Vidal M, et al
    Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings.
    J Med Virol. 2024;96:e29713.
    PubMed         Abstract available
  28. SHI P, Wang R, Liu E, Deng Y, et al
    Timing patterns of initial respiratory syncytial virus infection and factors influencing disease severity in hospitalized infants with different health status.
    J Med Virol. 2024;96:e29719.
    PubMed         Abstract available
  29. LEE S, Jo H, Lee H, Lee H, et al
    Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
    J Med Virol. 2024;96:e29693.
    PubMed         Abstract available


    J Travel Med
  30. WEE LE, Lim JT, Tan JYJ, Malek MIBA, et al
    Dengue versus COVID-19: Comparing the incidence of cardiovascular, neuropsychiatric, and autoimmune complications.
    J Travel Med. 2024 Jun 12:taae081. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  31. ZHU J, Wang Z, Li Y, Zhang Z, et al
    Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice.
    J Virol. 2024 Jun 14:e0052124. doi: 10.1128/jvi.00521.
    PubMed         Abstract available
  32. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    PubMed         Abstract available
  33. LI L, Li H, Qiu Y, Li J, et al
    PA-824 inhibits porcine epidemic diarrhea virus infection in vivo and in vitro by inhibiting p53 activation.
    J Virol. 2024 Jun 12:e0041323. doi: 10.1128/jvi.00413.
    PubMed         Abstract available
  34. ZHANG Y, Yang N, Li Y, Tan C, et al
    Transmissible gastroenteritis virus induces inflammatory responses via RIG-I/NF-kappaB/HIF-1alpha/glycolysis axis in intestinal organoids and in vivo.
    J Virol. 2024;98:e0046124.
    PubMed         Abstract available
  35. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    PubMed         Abstract available


    JAMA
  36. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed         Abstract available
  37. ABDUL-AZIZ MH, Hammond NE, Brett SJ, Cotta MO, et al
    Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    JAMA. 2024 Jun 12:e249803. doi: 10.1001/jama.2024.9803.
    PubMed         Abstract available
  38. VAN DER LINDEN S, Roozenbeek J
    “Inoculation” to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed        


    Lancet
  39. ANIRVAN P
    Blowing in the wind-India’s health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed        
  40. MOHAPATRA PR
    Responding to India’s data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed        
  41. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed        
  42. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial – Authors’ reply.
    Lancet. 2024;403:2484-2485.
    PubMed        
  43. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed        
  44. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed        
  45. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed         Abstract available


    Life Sci
  46. ENDO HM, Bandeca SCS, Olchanheski LR, Schemczssen-Graeff Z, et al
    Probiotics and the reduction of SARS-CoV-2 infection through regulation of host cell calcium dynamics.
    Life Sci. 2024;350:122784.
    PubMed         Abstract available


    N Engl J Med
  47. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed        
  48. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts – Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed        


    Nature
  49. WONG C
    What causes long COVID? Case builds for rogue antibodies.
    Nature. 2024 Jun 13. doi: 10.1038/d41586-024-02010.
    PubMed        


    Radiol Artif Intell
  50. VEIGA-CANUTO D, Fernandez-Paton M, Cerda Alberich L, Jimenez Pastor A, et al
    Reproducibility Analysis of Radiomic Features from T2-weighted MRI after Processing and Segmentation Alternations in Neuroblastoma Tumors.
    Radiol Artif Intell. 2024 Jun 12:e230208. doi: 10.1148/ryai.230208.
    PubMed         Abstract available


    Science
  51. KAISER J
    In testy hearing, Anthony Fauci confronts critics.
    Science. 2024;384:1057.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi
  52. ZHANG Z, Zhou M
    [COVID-19 and autoimmune dysregulation: exploring common mechanisms and treatment strategies in interstitial lung disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:571-575.
    PubMed         Abstract available
  53. HE LX
    [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:576-581.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO.com, June 15 ’24)

  1. ZHAI G, Fu W, Yuan S, Sun P, et al
    A fusion protein approach to integrate antiviral and anti-inflammatory activities for developing new therapeutics against influenza A virus infection.
    Antiviral Res. 2024 Jun 9:105924. doi: 10.1016/j.antiviral.2024.105924.
    PubMed         Abstract available
  2. LI J, Cui H, Yao Y, Niu J, et al
    Anti-influenza activity of CPAVM1 protease secreted by Bacillus subtilis LjM2.
    Antiviral Res. 2024 Jun 6:105919. doi: 10.1016/j.antiviral.2024.105919.
    PubMed         Abstract available


    BMJ
  3. MAHASE E
    Bird flu: First person with confirmed H5N2 infection dies.
    BMJ. 2024;385:q1260.
    PubMed        
  4. SMITH C
    Infected blood inquiry: justice will only be delivered when all the recommendations are acted upon.
    BMJ. 2024;385:q1256.
    PubMed        
  5. VIZE R
    What are the early election promises on health?
    BMJ. 2024;385:q1258.
    PubMed        
  6. MAHASE E
    Bird flu: Australia records first human case of H5N1.
    BMJ. 2024;385:q1281.
    PubMed        
  7. DEAN E
    Why I . . . make free flight aircraft.
    BMJ. 2024;385:q1157.
    PubMed        
  8. KMIETOWICZ Z
    Sixty seconds on . . . flying.
    BMJ. 2024;385:q1266.
    PubMed        
  9. TORJESEN I
    Hospital doctors in Wales to vote on enhanced pay deal for 2023-24.
    BMJ. 2024;385:q1273.
    PubMed        
  10. MAHASE E
    RCP president is asked to resign over handling of physician associates row.
    BMJ. 2024;385:q1291.
    PubMed        
  11. LAL N
    Study on adverse effects following Covaxin stirs heated debate in India.
    BMJ. 2024;385:q1300.
    PubMed        
  12. IACOBUCCI G
    Tories pledge to slash number of NHS managers to fund health spending.
    BMJ. 2024;385:q1297.
    PubMed        
  13. SADGROVE NEE STACEY C
    Help create an opportunity to learn together.
    BMJ. 2024;385:q868.
    PubMed        
  14. SHEPHERD A
    Striking doctors rally in Stormont.
    BMJ. 2024;385:q1280.
    PubMed        
  15. MAHASE E
    Bird flu: India reports human case of H9N2 in 4 year old.
    BMJ. 2024;385:q1317.
    PubMed        
  16. RIMMER A
    Four year medical degree set to launch in 2026, says NHS England.
    BMJ. 2024;385:q1312.
    PubMed        

  17. Seven days in medicine: 5-11 June 2024.
    BMJ. 2024;385:q1278.
    PubMed        
  18. KMIETOWICZ Z
    Labour vows to “fix NHS again” after Tories leave it “broken”.
    BMJ. 2024;385:q1315.
    PubMed        


    J Clin Microbiol
  19. MARGULIS M, Rohana H, Erster O, Mandelboim M, et al
    Highly sensitive extraction-free saliva-based molecular assay for rapid diagnosis of SARS-CoV-2.
    J Clin Microbiol. 2024;62:e0060024.
    PubMed         Abstract available
  20. POWELL EA, Greninger AL, Marlowe EM, Naccache SN, et al
    Proceedings of the Clinical Microbiology Open 2023: discussions about pandemic preparedness.
    J Clin Microbiol. 2024;62:e0014424.
    PubMed         Abstract available


    J Epidemiol Community Health
  21. RHEAD R, Wels J, Moltrecht B, Shaw RJ, et al
    Long COVID and financial outcomes: evidence from four longitudinal population surveys.
    J Epidemiol Community Health. 2024;78:458-465.
    PubMed         Abstract available


    J Infect Dis
  22. ATTUR M, Petrilli C, Adhikari S, Iturrate E, et al
    Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.
    J Infect Dis. 2024;229:1740-1749.
    PubMed         Abstract available
  23. HARTELOH P, van Mechelen R
    Reply to Mattiuzzi and Lippi.
    J Infect Dis. 2024;229:1930.
    PubMed        
  24. MATTIUZZI C, Lippi G
    Historical Comparison Between the Death Rate for Spanish Flu and Coronavirus Disease 2019 in Italy.
    J Infect Dis. 2024;229:1928-1929.
    PubMed        
  25. GAY L, Rouviere MS, Mezouar S, Richaud M, et al
    Vgamma9Vdelta2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19.
    J Infect Dis. 2024;229:1759-1769.
    PubMed         Abstract available
  26. IVERSEN KK, Ronit A, Ahlstrom MG, Nordestgaard BG, et al
    Lung Function Trajectories in Mild COVID-19 With 2-year Follow-up.
    J Infect Dis. 2024;229:1750-1758.
    PubMed         Abstract available
  27. CARROLL TD, Wong T, Morris MK, Di Germanio C, et al
    Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
    J Infect Dis. 2024 Jan 12:jiad568. doi: 10.1093.
    PubMed         Abstract available
  28. ZHANG Y, Zhou Y, Chen J, Wu J, et al
    Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.
    J Infect Dis. 2023 Dec 27:jiad572. doi: 10.1093.
    PubMed         Abstract available
  29. LACOURSE SM, Wetzler EA, Aurelio MC, Escudero JN, et al
    Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
    J Infect Dis. 2024;229:1728-1739.
    PubMed         Abstract available
  30. LIM SY, Kim JW, Kim JY, Kang SW, et al
    The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study.
    J Infect Dis. 2024;229:1722-1727.
    PubMed         Abstract available


    J Virol
  31. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    PubMed         Abstract available
  32. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6′ active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    PubMed         Abstract available
  33. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    PubMed         Abstract available
  34. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    PubMed         Abstract available
  35. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    PubMed         Abstract available


    JAMA
  36. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed        
  37. VAN DER LINDEN S, Roozenbeek J
    “Inoculation” to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed        


    Lancet
  38. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed         Abstract available
  39. ANIRVAN P
    Blowing in the wind-India’s health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed        
  40. MOHAPATRA PR
    Responding to India’s data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed        
  41. THE LANCET
    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    PubMed        
  42. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed        
  43. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial – Authors’ reply.
    Lancet. 2024;403:2484-2485.
    PubMed        
  44. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed        
  45. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed        


    N Engl J Med
  46. KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al
    Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
    N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488.
    PubMed        
  47. OWUSU-ANSAH S, Green Rodgers P
    Reviving Hearts – Uniting Communities with Lifesaving Bystander CPR.
    N Engl J Med. 2024;390:2040-2041.
    PubMed        
  48. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed        


    PLoS Comput Biol
  49. HILL EM, Petrou S, de Lusignan S, Yonova I, et al
    Correction: Seasonal influenza: Modelling approaches to capture immunity propagation.
    PLoS Comput Biol. 2024;20:e1012213.
    PubMed         Abstract available
  50. RAWSON T, Hinsley W, Sonabend R, Semenova E, et al
    The impact of health inequity on spatial variation of COVID-19 transmission in England.
    PLoS Comput Biol. 2024;20:e1012141.
    PubMed         Abstract available


    PLoS One
  51. AMANI B, Amani B
    Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298772.
    PubMed         Abstract available
  52. KAKEE S, Kanai K, Tsuneki-Tokunaga A, Okuno K, et al
    Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children.
    PLoS One. 2024;19:e0299445.
    PubMed         Abstract available
  53. MORGENSTERN C, Laydon DJ, Whittaker C, Mishra S, et al
    The interaction of disease transmission, mortality, and economic output over the first 2 years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0301785.
    PubMed         Abstract available
  54. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2024;19:e0305160.
    PubMed         Abstract available
  55. CHANG O, Levitt A, Khalid M, Kodeeswaran S, et al
    The prevalence of mental health and addiction concerns and factors associated with depression and anxiety during the COVID-19 pandemic in Ontario, Canada: A cross-sectional study.
    PLoS One. 2024;19:e0305229.
    PubMed         Abstract available
  56. WU Y, Namilae S, Srinivasan A, Mubayi A, et al
    Parametric analysis of SARS-CoV-2 dose-response models in transportation scenarios.
    PLoS One. 2024;19:e0301996.
    PubMed         Abstract available
  57. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2024;19:e0305043.
    PubMed         Abstract available
  58. MOJEBI A, Wu P, Keeping S, Hale B, et al
    Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.
    PLoS One. 2024;19:e0303560.
    PubMed         Abstract available
  59. IBRAHIM MR, Lyons T
    FaceTouch: Detecting hand-to-face touch with supervised contrastive learning to assist in tracing infectious diseases.
    PLoS One. 2024;19:e0288670.
    PubMed         Abstract available
  60. LEE SH, Ten Cate O, Gottlieb M, Horsley T, et al
    The use of virtual nominal groups in healthcare research: An extended scoping review.
    PLoS One. 2024;19:e0302437.
    PubMed         Abstract available
  61. FAIRCLOUGH SJ, Clifford L, Foweather L, Knowles ZR, et al
    Move Well, Feel Good: Feasibility and acceptability of a school-based motor competence intervention to promote positive mental health.
    PLoS One. 2024;19:e0303033.
    PubMed         Abstract available
  62. DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
    COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
    PLoS One. 2024;19:e0305314.
    PubMed         Abstract available
  63. NJUMA LIBWEA J, Esso L, Njoh AA, Ngwa CH, et al
    Generating the evidence to support the establishment of a Respiratory Syncytial Virus surveillance system in Cameroon: A study protocol.
    PLoS One. 2024;19:e0303468.
    PubMed         Abstract available
  64. YUH WT, Kim J, Kim MS, Kim JH, et al
    Trends in degenerative lumbar spinal surgery during the early COVID-19 pandemic in Republic of Korea: A national study utilizing the national health insurance database.
    PLoS One. 2024;19:e0305128.
    PubMed         Abstract available
  65. ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
    A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
    PLoS One. 2024;19:e0304616.
    PubMed         Abstract available
  66. AHMED Z, Gu Y, Sinha K, Mutowo M, et al
    A qualitative exploration of the over-the-counter availability of oral contraceptive pills in Australia.
    PLoS One. 2024;19:e0305085.
    PubMed         Abstract available
  67. CHEONG Q, Kazanjian A, Puyat JH
    Easing anxiety symptoms through leisure activities during social isolation: Findings from nationally representative samples.
    PLoS One. 2024;19:e0303585.
    PubMed         Abstract available
  68. OCHWADA-DOYLE FA, Miles N, Hughes JM, Murphy JJ, et al
    Exploring spatio-temporal changes in coastal recreational fisheries and potential links to extreme weather events.
    PLoS One. 2024;19:e0305106.
    PubMed         Abstract available
  69. CHIEN LC, Marquez ER, Smith S, Tu T, et al
    Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
    PLoS One. 2024;19:e0302934.
    PubMed         Abstract available
  70. PENG T, Duong KS, Lu JY, Chacko KR, et al
    Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.
    PLoS One. 2024;19:e0303151.
    PubMed         Abstract available
  71. FEATHERSTONE AB, Mathijssen AJTM, Brown A, Chitlapilly Dass S, et al
    SARS-CoV-2 Delta variant remains viable in environmental biofilms found in meat packaging plants.
    PLoS One. 2024;19:e0304504.
    PubMed         Abstract available
  72. MCHENGA M, Ndasauka Y, Kondowe F, Kainja J, et al
    Mental health is just an Addendum: Assessing stakeholder’s perceptions on COVID-19 and mental health services provision in Malawi.
    PLoS One. 2024;19:e0305341.
    PubMed         Abstract available
  73. CHICOINE N, Schnipper N, Griffin J
    The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    PLoS One. 2024;19:e0304416.
    PubMed         Abstract available
  74. YANG J, Fang H
    Integrating Embodied Social Presence Theory and Process Virtualization Theory to assess business process virtualizability: The mediating role of embodied co-presence.
    PLoS One. 2024;19:e0305423.
    PubMed         Abstract available
  75. TROTTA E, Serio G, Monacis L, Carlucci L, et al
    The effects of the COVID-19 pandemic on Italian primary school children’s learning: A systematic review through a psycho-social lens.
    PLoS One. 2024;19:e0303991.
    PubMed         Abstract available
  76. CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
    Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
    PLoS One. 2024;19:e0305553.
    PubMed         Abstract available
  77. GONZALEZ SUAREZ ML, Mara KC, Rivera CG, Chesdachai S, et al
    Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    PLoS One. 2024;19:e0303896.
    PubMed         Abstract available
  78. ETTMAN CK, Cohen GH, Abdalla SM, Hatton CR, et al
    Depression and assets during the COVID-19 pandemic: A longitudinal study of mental health across income and savings groups.
    PLoS One. 2024;19:e0304549.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  79. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
    Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
    Proc Natl Acad Sci U S A. 2024;121:e2314262121.
    PubMed         Abstract available
  80. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed         Abstract available
  81. MCGOUGH L, Cobey S
    A speed limit on serial strain replacement from original antigenic sin.
    Proc Natl Acad Sci U S A. 2024;121:e2400202121.
    PubMed         Abstract available


    Vaccine
  82. LI J, Gong L, Li J, Gong Z, et al
    Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster.
    Vaccine. 2024;42:3751-3755.
    PubMed         Abstract available
  83. SHANI M, Hermesh I, Feldhamer I, Reges O, et al
    The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities.
    Vaccine. 2024 May 9:S0264-410X(24)00536-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  84. URQUIDI C, Sepulveda-Penaloza A, Valenzuela MT, Ponce A, et al
    Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs.
    Vaccine. 2024 May 14:S0264-410X(24)00538-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  85. PROSPER P, Rodriguez Puertas R, Guerin DMA, Branda MM, et al
    Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers.
    Vaccine. 2024 May 22:S0264-410X(24)00584-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  86. SOE P, Wong H, Naus M, Muller MP, et al
    mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
    Vaccine. 2024 May 6:S0264-410X(24)00535-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  87. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed         Abstract available
  88. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, June 8 ’24)

  1. LE UNP, Chang YJ, Lu CH, Chen Y, et al
    Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
    Antiviral Res. 2024;227:105920.
    PubMed         Abstract available
  2. VAN LOY B, Stevaert A, Naesens L
    The coronavirus nsp15 endoribonuclease: a puzzling protein and pertinent antiviral drug target.
    Antiviral Res. 2024 May 31:105921. doi: 10.1016/j.antiviral.2024.105921.
    PubMed         Abstract available


    BMJ
  3. IACOBUCCI G
    Election watch: What are the main parties promising on health?
    BMJ. 2024;385:q1223.
    PubMed        
  4. WU KA
    Breaking the silence and confronting racism on the wards.
    BMJ. 2024;385:q1225.
    PubMed        
  5. TAYLOR L
    WHO member states agree better ways to detect health threats and set new deadline for pandemic treaty.
    BMJ. 2024;385:q1227.
    PubMed        
  6. DYER O
    Fauci is defiant as congressional hearing into covid origins fails to produce smoking gun.
    BMJ. 2024;385:q1231.
    PubMed        
  7. BHARMAL A, Sharma I, Majeed A, Pinder RJ, et al
    Foundation job allocation in the UK.
    BMJ. 2024;385:q1191.
    PubMed        
  8. DYER C
    Infected blood: an appalling medical tragedy.
    BMJ. 2024;385:q1179.
    PubMed        
  9. TOH CH, Buggins E
    Infected Blood Inquiry details failure after failure.
    BMJ. 2024;385:q1220.
    PubMed        
  10. KMIETOWICZ Z
    Value doctors or see NHS crisis worsen, BMA warns in manifesto for next government.
    BMJ. 2024;385:q1233.
    PubMed        
  11. CHRISTIE B
    Research England put politicians’ interests ahead of free speech, says EDI lead in resignation letter.
    BMJ. 2024;385:q1248.
    PubMed        
  12. CAVE E, Farsides B
    The infected blood scandal: lessons for clinical research.
    BMJ. 2024;385:q1205.
    PubMed        
  13. JONES B
    Suspension of former GP climate protester: don’t shoot the messenger.
    BMJ. 2024;385:q1234.
    PubMed        

  14. Seven days in medicine: 29 May to 4 June 2024.
    BMJ. 2024;385:q1221.
    PubMed        


    Clin Infect Dis
  15. BOECKH M, Pergam SA, Limaye AP, Englund J, et al
    How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic.
    Clin Infect Dis. 2024 Jun 3:ciae308. doi: 10.1093.
    PubMed         Abstract available

  16. Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jun 4:ciae257. doi: 10.1093.
    PubMed        
  17. NIMGAONKAR I, Flaherty PW, Oshima MU, Hill JA, et al
    Acute Endothelial Complications Post-Allogeneic Hematopoietic Cell Transplant in Patients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 4:ciae310. doi: 10.1093.
    PubMed        
  18. OLTOLINI C, Travi G, Mikulska M
    The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation.
    Clin Infect Dis. 2024 Jun 5:ciae307. doi: 10.1093.
    PubMed        


    Infect Control Hosp Epidemiol
  19. WEBER DJ, Malani AN, Shenoy ES, Banach DB, et al
    Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages.
    Infect Control Hosp Epidemiol. 2024 Jun 5:1-5. doi: 10.1017/ice.2024.
    PubMed         Abstract available
  20. BANACH DB, Mathew TA, Batshon LJ, Branch-Elliman W, et al
    SHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforce.
    Infect Control Hosp Epidemiol. 2024 Jun 5:1-4. doi: 10.1017/ice.2024.
    PubMed         Abstract available
  21. HSU VP, Haessler S, Banach DB, Batshon LJ, et al
    SHEA position statement on pandemic preparedness for policymakers: introduction and overview.
    Infect Control Hosp Epidemiol. 2024 Jun 5:1-3. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    Int J Infect Dis
  22. MAHYUDDIN AP, Swa HLF, Weng R, Zhang J, et al
    COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection.
    Int J Infect Dis. 2024 May 30:107121. doi: 10.1016/j.ijid.2024.107121.
    PubMed         Abstract available
  23. DE MENDOZA C, Lozano AB, Rando A, Carmen Nieto MD, et al
    The incidence of HIV-2 infection in Spain is declining – a registry data analysis.
    Int J Infect Dis. 2024 May 30:107076. doi: 10.1016/j.ijid.2024.107076.
    PubMed         Abstract available
  24. LOUBET P, Lelievre JD, Francois A, Botelho-Nevers E, et al
    Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study – ANRS0001s COV-POPART.
    Int J Infect Dis. 2024 May 31:107110. doi: 10.1016/j.ijid.2024.107110.
    PubMed         Abstract available


    J Infect
  25. JIANG J, Li Y, Jiang Q, Jiang Y, et al
    Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: a systematic review and network meta-analysis.
    J Infect. 2024 Jun 2:106190. doi: 10.1016/j.jinf.2024.106190.
    PubMed         Abstract available


    J Med Virol
  26. SAADE A, Didier Q, Cha L, Garlantezec R, et al
    The prevalence, determinants, and consequences of post-COVID in healthcare workers: A cross-sectional survey.
    J Med Virol. 2024;96:e29725.
    PubMed         Abstract available
  27. JURKOWICZ M, Cohen H, Nemet I, Keller N, et al
    Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015-2021: A retrospective cohort study.
    J Med Virol. 2024;96:e29709.
    PubMed         Abstract available
  28. XIONG X, Zheng Z, Liu C, Wang X, et al
    Unveiling the metabolic and coagulation disruptions in SARS-CoV-2-associated acute macular neuroretinopathy: A case-control study.
    J Med Virol. 2024;96:e29714.
    PubMed         Abstract available
  29. SONG K, Ye RZ, Li YY, Gong C, et al
    A Statovirus-like virus from respiratory tracts of patients, China.
    J Med Virol. 2024;96:e29711.
    PubMed         Abstract available


    J Travel Med
  30. KOMAKECH A, Baki KA, Izudi J
    Visa Relaxation Policies and Potential Implications on Public Health in Africa.
    J Travel Med. 2024;31:taae032.
    PubMed        


    J Virol
  31. SHI J, Hu S, Wei H, Zhang L, et al
    Dipeptidyl peptidase 4 interacts with porcine coronavirus PHEV spikes and mediates host range expansion.
    J Virol. 2024 Jun 3:e0075324. doi: 10.1128/jvi.00753.
    PubMed         Abstract available
  32. HU Y, Hao C, Wang D, Guo M, et al
    Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation.
    J Virol. 2024 Jun 3:e0033424. doi: 10.1128/jvi.00334.
    PubMed         Abstract available


    JAMA
  33. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    PubMed         Abstract available


    Lancet
  34. HORTON R
    Offline: UK election-two issues you won’t hear about.
    Lancet. 2024;403:2362.
    PubMed        
  35. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    PubMed        
  36. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    PubMed        
  37. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    PubMed        


    Lancet Infect Dis
  38. DE LUSIGNAN S, Shi T, Fowler T, Andrews N, et al
    Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions.
    Lancet Infect Dis. 2024 Jun 3:S1473-3099(24)00352.
    PubMed        


    Life Sci
  39. HSIEH MS, Chen MY, Chang YS, Huang CS, et al
    Targeting the Neuropilin-1 receptor with Ovatodiolide and progress in using periodontal ligament organoids for COVID-19 research and therapy.
    Life Sci. 2024 Jun 3:122764. doi: 10.1016/j.lfs.2024.122764.
    PubMed         Abstract available


    N Engl J Med
  40. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    PubMed        
  41. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    PubMed        
  42. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    PubMed        


    Nature
  43. LENHARO M
    Hope for global pandemic treaty rises – despite missed deadline.
    Nature. 2024 Jun 3. doi: 10.1038/d41586-024-01658.
    PubMed        
  44. KOZLOV M, Wolf L
    ‘Preposterous’: Anthony Fauci denies cover-up of COVID origins during tense hearing.
    Nature. 2024 Jun 3. doi: 10.1038/d41586-024-01657.
    PubMed        
  45. PARK TJ
    Negotiating a pandemic treaty is just the first step – how will countries comply?
    Nature. 2024;630:9.
    PubMed        


    Science
  46. WAI J
    Missed connectionsThe Last Human Job: The Work of Connecting in a Disconnected World Allison J. Pugh Princeton University Press, 2024. 384 pp.
    Science. 2024;384:1075.
    PubMed         Abstract available
  47. GUEDES TB, Pires MM, Garraffoni ARS, Pareja M, et al
    Brazil should prioritize young scientists at home.
    Science. 2024;384:1077.
    PubMed        
  48. COHEN J
    Global pandemic treaty stalls, again, over equity concerns.
    Science. 2024;384:1054.
    PubMed         Abstract available


    Travel Med Infect Dis
  49. KOISO S, Gulbas E, Dike L, Mulroy NM, et al
    Modeling approaches to inform travel-related policies for COVID-19 containment: a scoping review and future directions.
    Travel Med Infect Dis. 2024 Jun 1:102730. doi: 10.1016/j.tmaid.2024.102730.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, June 8 ’24)

  1. COLLAMORE G, DiCorcia MJ, Nagpal Y, Fiedler L, et al
    Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19.
    Am J Med. 2024;137:490-493.
    PubMed         Abstract available
  2. WU Y, Sawano M, Wu Y, Shah RM, et al
    Factors Associated With Long COVID: Insights From Two Nationwide Surveys.
    Am J Med. 2024;137:515-519.
    PubMed         Abstract available
  3. TAN BJ, Lo YL, Chan LL, Tan EK, et al
    Re-Emergence of Childhood Restless Legs Syndrome in Adulthood Following COVID-19 Infection.
    Am J Med. 2024;137:e109-e110.
    PubMed        
  4. WINGO MT, Andersen CA, Bornstein SL, Huber JM, et al
    Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2023.
    Am J Med. 2024;137:494-499.
    PubMed         Abstract available
  5. QUAN SF, Weaver MD, Czeisler ME, Barger LK, et al
    Association of Obstructive Sleep Apnea with Post-Acute Sequelae of SARS-CoV-2 Infection.
    Am J Med. 2024;137:529-537.
    PubMed         Abstract available


    Biochem Biophys Res Commun
  6. TACHIBANA K, Nakamura Y, Do TL, Kihara T, et al
    Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.
    Biochem Biophys Res Commun. 2024;719:150120.
    PubMed         Abstract available


    BMJ
  7. LOOI MK
    Bird flu: US confirms first case with respiratory symptoms.
    BMJ. 2024;385:q1203.
    PubMed        
  8. IACOBUCCI G
    Election watch: What are the main parties promising on health?
    BMJ. 2024;385:q1223.
    PubMed        
  9. WU KA
    Breaking the silence and confronting racism on the wards.
    BMJ. 2024;385:q1225.
    PubMed        
  10. DYE C, Barclay WS
    Should we worry about a growing threat from “bird flu”?
    BMJ. 2024;385:q1199.
    PubMed        
  11. TAYLOR L
    WHO member states agree better ways to detect health threats and set new deadline for pandemic treaty.
    BMJ. 2024;385:q1227.
    PubMed        
  12. DYER O
    Fauci is defiant as congressional hearing into covid origins fails to produce smoking gun.
    BMJ. 2024;385:q1231.
    PubMed        
  13. BHARMAL A, Sharma I, Majeed A, Pinder RJ, et al
    Foundation job allocation in the UK.
    BMJ. 2024;385:q1191.
    PubMed        
  14. DYER C
    Infected blood: an appalling medical tragedy.
    BMJ. 2024;385:q1179.
    PubMed        
  15. TOH CH, Buggins E
    Infected Blood Inquiry details failure after failure.
    BMJ. 2024;385:q1220.
    PubMed        
  16. KMIETOWICZ Z
    Value doctors or see NHS crisis worsen, BMA warns in manifesto for next government.
    BMJ. 2024;385:q1233.
    PubMed        
  17. CHRISTIE B
    Research England put politicians’ interests ahead of free speech, says EDI lead in resignation letter.
    BMJ. 2024;385:q1248.
    PubMed        
  18. CAVE E, Farsides B
    The infected blood scandal: lessons for clinical research.
    BMJ. 2024;385:q1205.
    PubMed        
  19. JONES B
    Suspension of former GP climate protester: don’t shoot the messenger.
    BMJ. 2024;385:q1234.
    PubMed        

  20. Seven days in medicine: 29 May to 4 June 2024.
    BMJ. 2024;385:q1221.
    PubMed        


    J Immunol
  21. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    PubMed         Abstract available


    J Infect
  22. CAI J, Lai L, Li R, Lin Q, et al
    The H5 subtype of avian influenza virus jumped across species to humans – a view from China.
    J Infect. 2024 Jun 1:106193. doi: 10.1016/j.jinf.2024.106193.
    PubMed        


    J Virol Methods
  23. ZHOU H, Li H, Sun X, Lin J, et al
    Rapid diagnosis of Canine respiratory coronavirus, Canine influenza virus, Canine distemper virus and Canine parainfluenza virus with a Taqman probe-based multiplex real-time PCR.
    J Virol Methods. 2024 May 30:114960. doi: 10.1016/j.jviromet.2024.114960.
    PubMed         Abstract available


    JAMA
  24. ABBASI J
    Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns.
    JAMA. 2024;331:1789-1791.
    PubMed        


    Lancet
  25. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    PubMed        
  26. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    PubMed        
  27. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    PubMed        
  28. HORTON R
    Offline: UK election-two issues you won’t hear about.
    Lancet. 2024;403:2362.
    PubMed        


    N Engl J Med
  29. BUONSENSO D
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034.
    PubMed        
  30. XU L, Huang X, Li Y
    Cognition and Memory after Covid-19 in a Large Community Sample.
    N Engl J Med. 2024;390:2034-2035.
    PubMed        
  31. HAMPSHIRE A, Elliott P
    Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
    N Engl J Med. 2024;390:2035.
    PubMed        


    Pediatrics

  32. Successes and Lessons Learned in Responding to the Needs of Pediatricians, Children, and Families During the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2024066634.
    PubMed         Abstract available
  33. PRICE AMH, Measey MA, Hoq M, Rhodes A, et al
    Caregiver and Child Mental Health During 3 Years of the COVID-19 Pandemic.
    Pediatrics. 2024;153:e2023064658.
    PubMed         Abstract available
  34. BURNS JE, Dahlen A, Bio LL, Chamberlain LJ, et al
    Prescribing Patterns of Nonrecommended Medications for Children With Acute COVID-19.
    Pediatrics. 2024;153:e2023065003.
    PubMed         Abstract available


    PLoS One
  35. LEE H, Kennedy CJ, Tu A, Restivo J, et al
    Patterns and correlates of mental healthcare utilization during the COVID-19 pandemic among individuals with pre-existing mental disorder.
    PLoS One. 2024;19:e0303079.
    PubMed         Abstract available
  36. KHORAMJOO M, Wang K, Srinivasan K, Gheblawi M, et al
    Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition.
    PLoS One. 2024;19:e0304522.
    PubMed         Abstract available
  37. OLIVEIRA MDS, Carvalho RF, Meurer CM, Rodrigues EM, et al
    Prevalence, under-reporting, and epidemiological surveillance of COVID-19 in the Araguaina City of Brazil.
    PLoS One. 2024;19:e0300191.
    PubMed         Abstract available
  38. STANISLAWEK WL, Tana T, Rawdon TG, Cork SC, et al
    Avian influenza viruses in New Zealand wild birds, with an emphasis on subtypes H5 and H7: Their distinctive epidemiology and genomic properties.
    PLoS One. 2024;19:e0303756.
    PubMed         Abstract available
  39. DAYAN RR, Blau M, Taylor J, Hasidim A, et al
    Lung ultrasound is associated with distinct clinical phenotypes in COVID-19 ARDS: A retrospective observational study.
    PLoS One. 2024;19:e0304508.
    PubMed         Abstract available
  40. SILVA AAPD, Reis RS, Iachecen F, Duarte F, et al
    First year of COVID-19 in Brazil: Factors associated with the spread of COVID-19 in small and large cities.
    PLoS One. 2024;19:e0298826.
    PubMed         Abstract available
  41. MAGNUS KD, Dammann N, Ziegler E, Ludecke D, et al
    Political party affiliation, social identity cues, and attitudes about protective mask-wearing during the COVID-19 pandemic in Germany.
    PLoS One. 2024;19:e0302399.
    PubMed         Abstract available
  42. AGARWAL A, Canfield C
    Analysis of rural broadband adoption dynamics: A theory-driven agent-based model.
    PLoS One. 2024;19:e0302146.
    PubMed         Abstract available
  43. VARMA JK, Zang C, Carton TW, Block JP, et al
    Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program.
    PLoS One. 2024;19:e0282451.
    PubMed         Abstract available
  44. GLEESON H, Earnshaw J, Craig C, Hodson C, et al
    Evaluation of the impact of the COVID-19 pandemic on a smoking cessation service in Derbyshire: An interrupted time series analysis.
    PLoS One. 2024;19:e0303876.
    PubMed         Abstract available
  45. SASSE K, Mahabir R, Gkountouna O, Crooks A, et al
    Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
    PLoS One. 2024;19:e0301488.
    PubMed         Abstract available
  46. BINSWANGER IA, Palmer-Toy DE, Barrow JC, Narwaney KJ, et al
    Assessing the association between antibody status and symptoms of long COVID: A multisite study.
    PLoS One. 2024;19:e0304262.
    PubMed         Abstract available
  47. BUTT AA, Yan P, Shaikh OS
    Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression.
    PLoS One. 2024;19:e0298254.
    PubMed         Abstract available
  48. SAMOUR A, AlGhazali A, Gadoiu M, Banuta M, et al
    Capital structure and financial performance of China’s energy industry: What can we infer from COVID-19?
    PLoS One. 2024;19:e0300936.
    PubMed         Abstract available
  49. IVYNIAN SE, Maccallum F, Chang S, Breen LJ, et al
    Support needs of Australians bereaved during the COVID-19 pandemic: A cross-sectional survey study.
    PLoS One. 2024;19:e0304025.
    PubMed         Abstract available
  50. REYGAERTS H, Smith S, Renner LM, Ruiz Y, et al
    A qualitative content analysis of cannabis-related discussions on Reddit during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304336.
    PubMed         Abstract available
  51. LE TT, Liao X
    Two-part predictive modeling for COVID-19 cases and deaths in the U.S.
    PLoS One. 2024;19:e0302324.
    PubMed         Abstract available
  52. MUCHANGI JM, Munai D, Moraro R, Thorseth AH, et al
    Lessons from the deployment and management of public handwashing stations in response to the COVID-19 pandemic in Kenya: A cross-sectional, observational study.
    PLoS One. 2024;19:e0303073.
    PubMed         Abstract available
  53. GARG N, Tellier G, Vale N, Kluge J, et al
    Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
    PLoS One. 2024;19:e0303450.
    PubMed         Abstract available
  54. BARI A, Alam MR, Islam S, Islam MN, et al
    Proximal tubular dysfunction as a predictor of AKI in Hospitalized COVID-19 patients.
    PLoS One. 2024;19:e0298408.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  55. GUO YT, Jiang JB, Qiao GR, Luo RH, et al
    Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2321619121.
    PubMed         Abstract available
  56. GUILLEN JV, Glaunsinger BA
    SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.
    Proc Natl Acad Sci U S A. 2024;121:e2408794121.
    PubMed        


    Vaccine
  57. MCDERMID P, Abdi I, Mustafa K, Blazek K, et al
    Examining the influence of community leaders and other community actors on immunisation practices in Australia: A national cross-sectional study.
    Vaccine. 2024;42:3647-3654.
    PubMed         Abstract available
  58. FENG J, Du Y, Chen L, Su W, et al
    A quadrivalent recombinant influenza Hemagglutinin vaccine induced strong protective immune responses in animal models.
    Vaccine. 2024 Jun 3:S0264-410X(24)00624-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  59. GOBIN S, Sahakyan G, Kusi Appiah M, Manukyan A, et al
    Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia – 2020-2021.
    Vaccine. 2024 Jun 4:S0264-410X(24)00623-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  60. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
    Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
    Virology. 2024;596:110124.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 1 ’24)

  1. FRANCO-MAY DA, Gomez-Carballo J, Barrera-Badillo G, Cruz-Ortiz MN, et al
    Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Antiviral Res. 2024;227:105918.
    PubMed         Abstract available


    Arch Virol
  2. HE L, Cao J, Xie X, Zhang Y, et al
    Effects and mechanism of Qingke Pingchuan granules against influenza virus infection.
    Arch Virol. 2024;169:130.
    PubMed         Abstract available


    BMC Pediatr
  3. AL-KUWARI MG, Mohammed AM, Abdulmajeed J, Al-Romaihi H, et al
    COVID-19 testing, incidence, and positivity trends among school age children during the academic years 2020-2022 in the State of Qatar: special focus on using CDC indicators for community transmission to evaluate school attendance policies and public
    BMC Pediatr. 2024;24:374.
    PubMed         Abstract available


    BMJ
  4. REYNOLDS C, Naqvi H
    Better use of data can help to prevent future deaths.
    BMJ. 2024;385:q1181.
    PubMed        
  5. LYNN E
    May top picks: politics, psychological safety, and creativity.
    BMJ. 2024;385:q1166.
    PubMed        
  6. TAYLOR L
    Pandemic treaty: panel calls for “reset” to talks as negotiators miss deadline.
    BMJ. 2024;385:q1193.
    PubMed        
  7. LIMB M
    Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
    BMJ. 2024;385:q1186.
    PubMed        
  8. KMIETOWICZ Z
    Junior doctors in England announce five day walkout ahead of general election.
    BMJ. 2024;385:q1183.
    PubMed        
  9. MAHASE E
    GPs could threaten mass resignation over NHS contract.
    BMJ. 2024;385:q1182.
    PubMed        
  10. WISE J
    Improving infection prevention could avoid 750 000 deaths a year, say experts.
    BMJ. 2024;385:q1163.
    PubMed        
  11. DYER O
    Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts.
    BMJ. 2024;385:q1172.
    PubMed        


    Epidemiol Infect
  12. YI B, Patrasova E, Simunkova L, Rost F, et al
    Investigating the cause of a 2021 winter wave of COVID-19 in a border region in eastern Germany: a mixed-methods study, August to November 2021.
    Epidemiol Infect. 2024;152:e87.
    PubMed         Abstract available


    J Infect
  13. SKAARUP KG, Lassen MCH, Modin D, Johansen ND, et al
    The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials.
    J Infect. 2024;89:106187.
    PubMed         Abstract available


    J Virol
  14. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., “Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses”.
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.
    PubMed        
  15. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., “Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses”.
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.
    PubMed        
  16. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., “N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies”.
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.
    PubMed        


    J Virol Methods
  17. MAK WA, Visser W, Koeleman JGM, Ong DSY, et al
    SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.
    J Virol Methods. 2024;327:114949.
    PubMed         Abstract available
  18. HAMILTON S, Zhu M, Cloney-Clark S, Mayes P, et al
    Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
    J Virol Methods. 2024;327:114945.
    PubMed         Abstract available
  19. EDWARDS K, Corocher T, Hersusianto Y, Campbell D, et al
    Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.
    J Virol Methods. 2024;327:114944.
    PubMed         Abstract available
  20. VASQUEZ V, Orozco J
    Clinical validation of SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex.
    J Virol Methods. 2024;327:114940.
    PubMed         Abstract available
  21. DOSBAA A, Guilbaud R, Yusti AF, Ferre VM, et al
    RSV-GenoScan: An automated pipeline for whole-genome human respiratory syncytial virus (RSV) sequence analysis.
    J Virol Methods. 2024;327:114938.
    PubMed         Abstract available
  22. OUSSET MJ, Pianciola LA, Mazzeo M, Oteiza JM, et al
    Improved SARS-CoV-2 RNA recovery in wastewater matrices using a CTAB-based extraction method.
    J Virol Methods. 2024;327:114918.
    PubMed         Abstract available


    Lancet
  23. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed        
  24. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed        
  25. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.
    PubMed        
  26. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed        


    MMWR Morb Mortal Wkly Rep
  27. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine – United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.
    PubMed        
  28. GARG S, Reed C, Davis CT, Uyeki TM, et al
    Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases – United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:501-505.
    PubMed        


    N Engl J Med
  29. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.
    PubMed        


    PLoS Comput Biol
  30. MASSEY A, Boennec C, Restrepo-Ortiz CX, Blanchet C, et al
    Real-time forecasting of COVID-19-related hospital strain in France using a non-Markovian mechanistic model.
    PLoS Comput Biol. 2024;20:e1012124.
    PubMed         Abstract available
  31. FOSTER ZSL, Tupper AS, Press CM, Grunwald NJ, et al
    Krisp: A Python package to aid in the design of CRISPR and amplification-based diagnostic assays from whole genome sequencing data.
    PLoS Comput Biol. 2024;20:e1012139.
    PubMed         Abstract available


    PLoS One
  32. KUCZYK C, Munch K, Nohre M, Stephan M, et al
    Development and testing of a questionnaire on the expectations and experiences with wearing face masks in inpatient and day hospitals.
    PLoS One. 2024;19:e0304140.
    PubMed         Abstract available
  33. HUANG W, Ichikohji T
    How dynamic capabilities enable Chinese SMEs to survive and thrive during COVID-19: Exploring the mediating role of business model innovation.
    PLoS One. 2024;19:e0304471.
    PubMed         Abstract available
  34. HABTEMARIAM S, Hery CM, Zhang X, Yu M, et al
    Association between sociodemographics and change in alcohol or tobacco use behaviors during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304111.
    PubMed         Abstract available
  35. CHEN Y, Li H, Lin J, Su Z, et al
    Association between (DeltaPaO2/FiO2)/PEEP and in-hospital mortality in patients with COVID-19 pneumonia: A secondary analysis.
    PLoS One. 2024;19:e0304518.
    PubMed         Abstract available
  36. ABDUL-MUMIN A, Bimpong KA, Cotache-Condor C, Oppong J, et al
    Impact of the COVID-19 pandemic on perinatal care and outcomes: A retrospective study in a tertiary hospital in Northern Ghana.
    PLoS One. 2024;19:e0301081.
    PubMed         Abstract available
  37. LIU N, Li Y, Jiang M, Liu B, et al
    Trade shocks and trade diversion due to epidemic diseases: Evidence from 110 countries.
    PLoS One. 2024;19:e0301828.
    PubMed         Abstract available
  38. TAO W, Zhou JY
    A study on the “Porter Hypothesis” effect of the regulatory measures of the environmental protection tax law in the post-pandemic era.
    PLoS One. 2024;19:e0304636.
    PubMed         Abstract available
  39. RAK A, Matyushenko V, Prokopenko P, Kostromitina A, et al
    A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.
    PLoS One. 2024;19:e0304534.
    PubMed         Abstract available
  40. NGOMTCHO SCH, Akenji BM, Tchio-Nighie KH, Fokam J, et al
    SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.
    PLoS One. 2024;19:e0304477.
    PubMed         Abstract available
  41. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    PubMed         Abstract available
  42. WELLSPRING I, Ganesh K, Kreklewetz K
    Walk-in mental health: Bridging barriers in a pandemic.
    PLoS One. 2024;19:e0302543.
    PubMed         Abstract available
  43. ELGEDAWY GA, Samir M, Elabd NS, Elsaid HH, et al
    Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
    PLoS One. 2024;19:e0302977.
    PubMed         Abstract available
  44. CAO D, Tahir SH, Rizvi SMR, Khan KB, et al
    Exploring the influence of women’s leadership and corporate governance on operational liquidity: The glass cliff effect.
    PLoS One. 2024;19:e0302210.
    PubMed         Abstract available
  45. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
    The effects of person-centred active rehabilitation on symptoms of suspected Chronic Traumatic Encephalopathy: A mixed-methods single case design.
    PLoS One. 2024;19:e0302260.
    PubMed         Abstract available
  46. RAHMAN A, Russell M, Zheng W, Eckrich D, et al
    SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).
    PLoS One. 2024;19:e0295891.
    PubMed         Abstract available
  47. KIMANI ME, Sarr M
    Association of race/ethnicity and severe housing problems with COVID-19 deaths in the United States: Analysis of the first three waves.
    PLoS One. 2024;19:e0303667.
    PubMed         Abstract available
  48. ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
    Can COVID-19 herd immunity be achieved at a city level?
    PLoS One. 2024;19:e0299574.
    PubMed         Abstract available
  49. YOUSEF CC, Farooq A, Amateau G, Abu Esba LC, et al
    The effect of job and personal demands and resources on healthcare workers’ wellbeing: A cross-sectional study.
    PLoS One. 2024;19:e0303769.
    PubMed         Abstract available
  50. DASARI H, Smyrnova A, Leng J, Ducharme FM, et al
    Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond.
    PLoS One. 2024;19:e0304155.
    PubMed         Abstract available
  51. BREBAN R
    Emergence failure of early epidemics: A mathematical modeling approach.
    PLoS One. 2024;19:e0301415.
    PubMed         Abstract available
  52. ACHEAMPONG E, Husain AA, Dudani H, Nayak AR, et al
    Population infection estimation from wastewater surveillance for SARS-CoV-2 in Nagpur, India during the second pandemic wave.
    PLoS One. 2024;19:e0303529.
    PubMed         Abstract available
  53. PASQUALE DK, Welsh W, Bentley-Edwards KL, Olson A, et al
    Homophily and social mixing in a small community: Implications for infectious disease transmission.
    PLoS One. 2024;19:e0303677.
    PubMed         Abstract available
  54. KEMPTHORNE J, Yogeeswaran K, Sibley CG, Bulbulia JA, et al
    The anatomy of prejudice during pandemic lockdowns: Evidence from a national panel study.
    PLoS One. 2024;19:e0303845.
    PubMed         Abstract available
  55. KLEINAU E, Lamba T, Jaskiewicz W, Gorentz K, et al
    Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial.
    PLoS One. 2024;19:e0303370.
    PubMed         Abstract available
  56. LE T, Flores M, Omaleki V, Hassani A, et al
    Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
    PLoS One. 2024;19:e0295618.
    PubMed         Abstract available
  57. RAKIB MI, Alam MJ, Akter N, Tuhin KH, et al
    Change in hierarchy of the financial networks: A study on firms of an emerging market in Bangladesh.
    PLoS One. 2024;19:e0301725.
    PubMed         Abstract available
  58. VOUTOURI C, Hardin CC, Naranbhai V, Nikmaneshi MR, et al
    Dynamic heterogeneity in COVID-19: Insights from a mathematical model.
    PLoS One. 2024;19:e0301780.
    PubMed         Abstract available
  59. ZHANG EY, Baldwin A, Hundley C, Chang E, et al
    Influence of an extreme event-the COVID-19 pandemic-On establishment of and data collection by a citizen science project.
    PLoS One. 2024;19:e0303429.
    PubMed         Abstract available
  60. ZHAO Y, Liu F, Lin P, Tu Z, et al
    Sleep quality and mental health among Chinese nurses after the COVID-19 pandemic: A moderated model.
    PLoS One. 2024;19:e0295105.
    PubMed         Abstract available
  61. SIMANDJUNTAK DP, Jaenicke EC, Wrenn DH
    Pandemic-induced changes in household-level food diversity and diet quality in the U.S.
    PLoS One. 2024;19:e0300839.
    PubMed         Abstract available
  62. SALMAN M, Zhu Y, Kiran S, Sibt E Ali M, et al
    Corporate social responsibility: A key driver of sustainable development in China’s post-COVID economy.
    PLoS One. 2024;19:e0300209.
    PubMed         Abstract available
  63. BALAMPAMA M, de Walque D, Dow WH, Hemono R, et al
    Influence of COVID-19 on female sex workers in Dar es Salaam, Tanzania: A mixed-methods analysis.
    PLoS One. 2024;19:e0303993.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  64. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
    Biophysical principles predict fitness of SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2314518121.
    PubMed         Abstract available
  65. QU B, Miskey C, Gomer A, Kleinert RDV, et al
    TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Proc Natl Acad Sci U S A. 2024;121:e2407437121.
    PubMed         Abstract available


    Vaccine
  66. XIE Z, Stallings-Smith S, Patel S, Case S, et al
    COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population.
    Vaccine. 2024 Apr 25:S0264-410X(24)00509-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  67. DORJEE K, Namdon T, Topgyal S, Gyatso U, et al
    Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
    Vaccine. 2024 Apr 27:S0264-410X(24)00500-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  68. MARINTHE G, Brown G, Cristea M, Kutlaca M, et al
    Predicting vaccination hesitancy: The role of basic needs satisfaction and institutional trust.
    Vaccine. 2024 May 3:S0264-410X(24)00507-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  69. BAGLIVO F, De Angelis L, Magri M, De Nicola I, et al
    The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents’ attitudes towards mandatory and recommended vaccination in Southern Italy.
    Vaccine. 2024 May 3:S0264-410X(24)00513-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  70. CHRISTOU-ERGOS M, Bleicher K, Leask J
    Factors associated with vaccination intention and uptake over time in a sample of older Australians.
    Vaccine. 2024 May 3:S0264-410X(24)00508-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  71. ADINUGROHO I, Stafford T, Bentall RP
    The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK.
    Vaccine. 2024 May 3:S0264-410X(24)00510-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  72. CARDENAS V, Le Gars M, Truyers C, Ruiz-Guinazu J, et al
    Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.
    Vaccine. 2024;42:3536-3546.
    PubMed         Abstract available
  73. MARANTOS T, Kyriazopoulou E, Angelakis E, Kitsos D, et al
    Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study.
    Vaccine. 2024 May 24:S0264-410X(24)00617-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  74. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed         Abstract available
  75. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed         Abstract available


    Virus Res
  76. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.
    PubMed        
  77. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed         Abstract available
  78. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed         Abstract available
  79. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed         Abstract available
  80. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed         Abstract available
  81. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed         Abstract available

#Influenza and Other Respiratory #Pathogens Research #References (by AMEDEO, May 18 ’24)

  1. ASADIPOOYA K, Asadipooya A, Adatorwovor R
    Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.
    Arch Virol. 2024;169:122.
    PubMed         Abstract available


    Biochem Biophys Res Commun
  2. KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al
    Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
    Biochem Biophys Res Commun. 2024;716:149954.
    PubMed         Abstract available


    BMC Pediatr
  3. AL-IEDE M, Alhouri A, Marwa K, Alnajjar R, et al
    Respiratory syncytial virus in pediatric patients admitted to a tertiary center in Amman: clinical characteristics, and age-related patterns.
    BMC Pediatr. 2024;24:334.
    PubMed         Abstract available
  4. JIANG Z, Fang C, Peng F, Fan W, et al
    Comparison of clinical characteristics and disease burden of febrile seizures in children with and without COVID-19.
    BMC Pediatr. 2024;24:329.
    PubMed         Abstract available
  5. HUANG L, Ye C, Zhou R, Ji Z, et al
    Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study.
    BMC Pediatr. 2024;24:328.
    PubMed         Abstract available


    BMJ
  6. WISE J
    Sixty seconds on . . . the pandemic treaty.
    BMJ. 2024;385:q1124.
    PubMed        
  7. MAHASE E
    Hospitals are urged to increase use of virtual wards to cut admissions.
    BMJ. 2024;385:q1123.
    PubMed        
  8. NOGRADY B
    Australia: Inductions and preterm births fell during early pandemic years.
    BMJ. 2024;385:q1112.
    PubMed        

  9. Seven days in medicine: 8-14 May 2024.
    BMJ. 2024;385:q1079.
    PubMed        
  10. LANG K
    What do we know about covid-19’s effects on the brain?
    BMJ. 2024;385:q897.
    PubMed        
  11. NAKWEYA G
    Doctors in Kenya end strike after threat of court action.
    BMJ. 2024;385:q1088.
    PubMed        
  12. MAHASE E
    Infective endocarditis: Coroner’s report questions NICE guidance on prevention.
    BMJ. 2024;385:q1081.
    PubMed        
  13. O’CONNOR RJ, Parkin A, Mir G, Mullard J, et al
    Work and vocational rehabilitation for people living with long covid.
    BMJ. 2024;385:e076508.
    PubMed        
  14. LOOI MK
    Sixty seconds on . . . Apple Watch.
    BMJ. 2024;385:q1063.
    PubMed        


    Cell
  15. HARTMANN JA, Cardoso MR, Talarico MCR, Kenney DJ, et al
    Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
    Cell. 2024;187:2393-2410.
    PubMed         Abstract available


    Drugs
  16. ZHU C, Pang S, Liu J, Duan Q, et al
    Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines.
    Drugs. 2024;84:403-423.
    PubMed         Abstract available


    Epidemiol Infect
  17. PARK JO, Cho HK, Jeon CH, Kim SH, et al
    Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
    Epidemiol Infect. 2024;152:e76.
    PubMed         Abstract available


    J Infect Dis
  18. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
    Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
    J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
    PubMed         Abstract available
  19. BEN MAMOUN C, Vydyam P
    Response to the Letter by Liu and Colleagues.
    J Infect Dis. 2024;229:1601.
    PubMed        
  20. FOTOOH ABADI L, Sharma MB, Kelesidis T
    Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Level.
    J Infect Dis. 2024;229:1382-1386.
    PubMed         Abstract available
  21. WONG M, Gain C, Sharma MB, Fotooh Abadi L, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo.
    J Infect Dis. 2024;229:1372-1381.
    PubMed         Abstract available
  22. KARABA AH, Morgenlander WR, Johnston TS, Hage C, et al
    Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
    J Infect Dis. 2023 Nov 29:jiad534. doi: 10.1093.
    PubMed         Abstract available
  23. DOS RAMOS ALMEIDA CJL, Veras FP, Paiva IM, Schneider AH, et al
    Neutrophil Virucidal Activity Against SARS-CoV-2 Is Mediated by Neutrophil Extracellular Traps.
    J Infect Dis. 2024;229:1352-1365.
    PubMed         Abstract available
  24. LEDUCQ V, Zafilaza K, Fauchois A, Ghidaoui E, et al
    Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.
    J Infect Dis. 2024;229:1341-1351.
    PubMed         Abstract available
  25. HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al
    Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
    J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093.
    PubMed         Abstract available


    J Virol
  26. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    PubMed         Abstract available
  27. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    PubMed         Abstract available
  28. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    PubMed         Abstract available
  29. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    PubMed         Abstract available
  30. PEREZ DR
    A devastating blow: personal reflections on Argentina’s scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    PubMed         Abstract available
  31. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    PubMed         Abstract available
  32. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    PubMed         Abstract available
  33. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    PubMed         Abstract available
  34. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    PubMed         Abstract available
  35. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    PubMed         Abstract available
  36. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    PubMed         Abstract available
  37. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    PubMed         Abstract available


    JAMA
  38. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed        

  39. Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed        
  40. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    PubMed        


    Lancet
  41. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    PubMed        
  42. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    PubMed        
  43. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    PubMed        
  44. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    PubMed        
  45. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won’t control transmission.
    Lancet. 2024;403:1850-1851.
    PubMed        
  46. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    PubMed        
  47. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    PubMed        


    N Engl J Med
  48. HERBERT C, McManus DD, Soni A
    False Positive Covid-19 Rapid Antigen Tests. Reply.
    N Engl J Med. 2024;390:1836.
    PubMed        
  49. YANG C, Espin E, Tebbutt SJ
    False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:1835-1836.
    PubMed        
  50. SCHUBACH A, Ricotta D, Kittleson MM
    To Preround or Not to Preround.
    N Engl J Med. 2024;390:1824-1826.
    PubMed        


    PLoS Comput Biol
  51. LOPEZ VK, Cramer EY, Pagano R, Drake JM, et al
    Challenges of COVID-19 Case Forecasting in the US, 2020-2021.
    PLoS Comput Biol. 2024;20:e1011200.
    PubMed         Abstract available
  52. ASPLIN P, Keeling MJ, Mancy R, Hill EM, et al
    Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.
    PLoS Comput Biol. 2024;20:e1012096.
    PubMed         Abstract available


    PLoS One
  53. BRETANA NA, Kwon JA, Grant L, Galouzis J, et al
    Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study.
    PLoS One. 2024;19:e0303062.
    PubMed         Abstract available
  54. SHERAK RAG, Sajjadi H, Khimani N, Tolchin B, et al
    SOFA score performs worse than age for predicting mortality in patients with COVID-19.
    PLoS One. 2024;19:e0301013.
    PubMed         Abstract available
  55. THAMPI N, Burhunduli T, Strain J, Raudanskis A, et al
    Detection of SARS-CoV-2 in schools using built environment testing in Ottawa, Canada: A multi-facility prospective surveillance study.
    PLoS One. 2024;19:e0300397.
    PubMed         Abstract available
  56. HARRIS J, Germain J, McCoy E, Schofield R, et al
    Ethical guidance for conducting health research with online communities: A scoping review of existing guidance.
    PLoS One. 2024;19:e0302924.
    PubMed         Abstract available
  57. FENG W, Zhao L, Ge Z, Zhao X, et al
    Association between physical activity and adolescent mental health in the post COVID-19: The chain mediating effect of self-esteem and social anxiety.
    PLoS One. 2024;19:e0301617.
    PubMed         Abstract available
  58. ESPOSITO G, Hunashal Y, Percipalle M, Fogolari F, et al
    Assessing nanobody interaction with SARS-CoV-2 Nsp9.
    PLoS One. 2024;19:e0303839.
    PubMed         Abstract available
  59. GUNAY-POLATKAN S, Caliskan S, Sigirli D
    Association of atherogenic indices with myocardial damage and mortality in COVID-19.
    PLoS One. 2024;19:e0302984.
    PubMed         Abstract available
  60. PANAHI R, Ghorbanpour Z, Moradi B, Eidy F, et al
    The relationship between health literacy and the adoption of COVID-19 preventive behaviors: A cross-sectional study in Iran.
    PLoS One. 2024;19:e0299007.
    PubMed         Abstract available
  61. UMEH GC, Cleenwerck de Kiev L, Mamza J, Atiku A, et al
    Symptoms of depression among outpatients with suspected COVID-19 in metropolitan Local Government Areas of Kaduna State, Nigeria.
    PLoS One. 2024;19:e0288567.
    PubMed         Abstract available
  62. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national “QazVac” vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    PubMed         Abstract available
  63. ZHOU Q, Zhao G, Pan Y, Zhang Y, et al
    The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials.
    PLoS One. 2024;19:e0300512.
    PubMed         Abstract available
  64. SHYU D, Bliss P, Adams A, Cho RJ, et al
    Development and performance evaluation of a solenoid valve assisted low-cost ventilator on gas exchange and respiratory mechanics in a porcine model.
    PLoS One. 2024;19:e0303443.
    PubMed         Abstract available
  65. DUNCAN G, Christensen WF, Handley C
    COVID-19 hotspot detection in a university setting.
    PLoS One. 2024;19:e0289254.
    PubMed         Abstract available
  66. OLIVEIRA ES, Nascimento ALBD, Ferreira Junior WS, Albuquerque UP, et al
    How does prestige bias affect information recall during a pandemic?
    PLoS One. 2024;19:e0303512.
    PubMed         Abstract available
  67. KHALIL B, Sharif-Askari NS, Hafezi S, Sharif-Askari FS, et al
    Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway.
    PLoS One. 2024;19:e0302818.
    PubMed         Abstract available
  68. KASPERSKA A, Matysiak A, Cukrowska-Torzewska E
    Managerial (dis)preferences towards employees working from home: Post-pandemic experimental evidence.
    PLoS One. 2024;19:e0303307.
    PubMed         Abstract available
  69. PARK J, Joo H, Kim D, Mase S, et al
    Cost-effectiveness of mask mandates on subways to prevent SARS-CoV-2 transmission in the United States.
    PLoS One. 2024;19:e0302199.
    PubMed         Abstract available
  70. BISHOP-EDWARDS L, Taylor Buck E, Weich S
    The delivery of creative socially prescribed activities for people with serious mental health needs during lockdown: Learning about remote, digital and hybrid delivery.
    PLoS One. 2024;19:e0301550.
    PubMed         Abstract available
  71. BABAR M, Qureshi B, Koubaa A
    Investigating the impact of data heterogeneity on the performance of federated learning algorithm using medical imaging.
    PLoS One. 2024;19:e0302539.
    PubMed         Abstract available
  72. HUNTER PR, Brainard J
    Changing risk factors for developing SARS-CoV-2 infection from Delta to Omicron.
    PLoS One. 2024;19:e0299714.
    PubMed         Abstract available
  73. ARGENIO KL, Day SE, D’Agostino EM, Neshteruk C, et al
    Increasing disparities in obesity and severe obesity prevalence among public elementary and middle school students in New York City, school years 2011-12 through 2019-20.
    PLoS One. 2024;19:e0302099.
    PubMed         Abstract available
  74. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    PubMed         Abstract available
  75. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    PubMed         Abstract available
  76. YANG Q, Chang A, Tong X, Jackson SL, et al
    Long-term cardiovascular disease outcomes in non-hospitalized medicare beneficiaries diagnosed with COVID-19: Population-based matched cohort study.
    PLoS One. 2024;19:e0302593.
    PubMed         Abstract available
  77. NHACOLO A, Magaco A, Amosse F, Hunguana A, et al
    Perceptions and compliance with COVID-19 preventive measures in Southern and Central regions of Mozambique: A quantitative in-person household survey in the districts of Manhica and Quelimane.
    PLoS One. 2024;19:e0278439.
    PubMed         Abstract available
  78. WANG B, Tong C, Chen T, Yang J, et al
    Evaluation of China’s live streaming e-commerce industry policies based on a three-dimensional analysis framework.
    PLoS One. 2024;19:e0301451.
    PubMed         Abstract available
  79. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    PubMed         Abstract available
  80. MEYER D, Lowensen K, Perrin N, Moore A, et al
    An evaluation of the impact of social and structural determinants of health on forgone care during the COVID-19 pandemic in Baltimore, Maryland.
    PLoS One. 2024;19:e0302064.
    PubMed         Abstract available
  81. FUKUYAMA K, Mori Y, Ueshima H, Ito S, et al
    Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2024;19:e0303493.
    PubMed         Abstract available
  82. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    PubMed         Abstract available
  83. GAO Y, Ma Y, Li Y, Zhao Y, et al
    Prevalence and correlates of mental disorders among Chinese overseas students during the COVID-19: A multi-regional cross-sectional analysis.
    PLoS One. 2024;19:e0303283.
    PubMed         Abstract available
  84. THOMAZELLI LM, Pinho JRR, Dorlass EG, Ometto T, et al
    Evidence of reassortment of avian influenza A (H2) viruses in Brazilian shorebirds.
    PLoS One. 2024;19:e0300862.
    PubMed         Abstract available
  85. BROWN RT, Zamora K, Rizzo A, Spar MJ, et al
    Improving measurement of functional status among older adults in primary care: A pilot study.
    PLoS One. 2024;19:e0303402.
    PubMed         Abstract available
  86. RYS M, Schollaert E, Van Hoye G
    Living the employer brand during a crisis? A qualitative study on internal employer branding in times of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303361.
    PubMed         Abstract available
  87. SIMONSSON O, Fisher SD
    Mindfulness meditation use in Britain during the COVID-19 pandemic.
    PLoS One. 2024;19:e0303349.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  88. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
    Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2402540121.
    PubMed         Abstract available
  89. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
    Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
    Proc Natl Acad Sci U S A. 2024;121:e2310677121.
    PubMed         Abstract available
  90. XIE Y, Yang F, Huang J, He Y, et al
    Declining Chinese attitudes toward the United States amid COVID-19.
    Proc Natl Acad Sci U S A. 2024;121:e2322920121.
    PubMed         Abstract available


    Vaccine
  91. CARNALLA M, Stern D, Arantxa Colchero M, Rangel-Moreno K, et al
    Who is getting COVID-19 boosters? A latent class analysis in a nationally representative sample of Mexican adults 60 years and over.
    Vaccine. 2024;42:3273-3276.
    PubMed         Abstract available
  92. LIEVRE G, Sicsic J, Galmiche S, Charmet T, et al
    Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France.
    Vaccine. 2024 Apr 19:S0264-410X(24)00438-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  93. RAMOS-DUARTE VA, Orlowski A, Jaquenod de Giusti C, Corigliano MG, et al
    Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.
    Vaccine. 2024;42:3355-3364.
    PubMed         Abstract available
  94. MELNIKOW J, Padovani A, Zhang J, Miller M, et al
    Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy.
    Vaccine. 2024 Apr 15:S0264-410X(24)00437-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  95. WONG IOL, Wong C, Mak N, Dai A, et al
    Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong.
    Vaccine. 2024 Apr 15:S0264-410X(24)00449-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  96. SUKIK L, Chemaitelly H, Ayoub HH, Coyle P, et al
    Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
    Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  97. LEE JS, Choi H, Shin SH, Hwang MJ, et al
    Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
    Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  98. THAI H, Audet EC, Koestner R
    Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis.
    Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virology
  99. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    PubMed         Abstract available
  100. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed         Abstract available
  101. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
    Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Virology. 2024;595:110068.
    PubMed         Abstract available

#Coronavirus Disease Research #References (by AMEDEO, May 11 ’24)

  1. MONZON R, Ornelas-Dorian C, Eucker SA, Rising K, et al
    An evaluation of COVID-19 vaccine messaging platforms in the emergency department.
    Acad Emerg Med. 2024 May 5. doi: 10.1111/acem.14933.
    PubMed        


    Antiviral Res
  2. SALGADO-BENVINDO C, Tas A, Zevenhoven-Dobbe JC, van der Meer Y, et al
    Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: a versatile and practical infection model for antiviral research and beyond.
    Antiviral Res. 2024 May 7:105903. doi: 10.1016/j.antiviral.2024.105903.
    PubMed         Abstract available


    BMJ

  3. Seven days in medicine: 1-7 May 2024.
    BMJ. 2024;385:q1022.
    PubMed        
  4. MAHASE E
    Workforce and winter under Labour: Wes Streeting on his plan for the NHS and ending the strikes.
    BMJ. 2024;385:q992.
    PubMed        
  5. WONG G, Kelly M
    NHS funding for a secure future: naming the elephant in the room.
    BMJ. 2024;385:q1036.
    PubMed        
  6. NAKWEYA G
    Moderna’s decision to shelve vaccine plant in Kenya should encourage global south’s self-reliance, says global health adviser.
    BMJ. 2024;385:q1051.
    PubMed        
  7. MAFI A
    Doctors in training should be at the top of the workforce priority list.
    BMJ. 2024;385:q1045.
    PubMed        
  8. WATERS A
    LMC removes GP from committee amid row over attendance at meetings.
    BMJ. 2024;385:q1021.
    PubMed        
  9. LOOI MK
    Why WHO changed the definition of “airborne transmission” in the wake of the pandemic.
    BMJ. 2024;385:q985.
    PubMed        
  10. LYNN E
    April top picks: Hope springs eternal.
    BMJ. 2024;385:q1037.
    PubMed        


    Clin Infect Dis
  11. ANDREWS JS, Boonyaratanakornkit JB, Krusinska E, Allen S, et al
    Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132.
    Clin Infect Dis. 2024 May 10:ciae205. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis
  12. XIANG Y, Feng Y, Qiu J, Zhang R, et al
    Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases: a study using data from the UK Biobank.
    Int J Infect Dis. 2024 May 1:107080. doi: 10.1016/j.ijid.2024.107080.
    PubMed         Abstract available
  13. SCOTT AJ, Limbada M, Perumal T, Jaumdally S, et al
    Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.
    Int J Infect Dis. 2024 May 1:107081. doi: 10.1016/j.ijid.2024.107081.
    PubMed         Abstract available
  14. VAN VOORDEN J, de Groot CJM, Ris-Stalpers C, Afink GB, et al
    Corrigendum to “COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development” [International Journal of Infectious Diseases, 140C (2024) pages 95-98].
    Int J Infect Dis. 2024;144:107068.
    PubMed        
  15. LIN DY, Xu Y, Gu Y, Sunny SK, et al
    Impact of Booster Vaccination Interval on SARS-CoV-2 Infection, Hospitalization, and Death.
    Int J Infect Dis. 2024 May 3:107084. doi: 10.1016/j.ijid.2024.107084.
    PubMed         Abstract available


    Intensive Care Med
  16. MONTOMOLI J, Vergano M, Semeraro F, Bignami EG, et al
    From the pandemic to a war: a call for solidarity with all healthcare workers.
    Intensive Care Med. 2024;50:776-777.
    PubMed        
  17. DE CORTE T, Kohler K, Cecconi M, De Waele JJ, et al
    Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic.
    Intensive Care Med. 2024 May 6. doi: 10.1007/s00134-024-07444.
    PubMed        


    Invest Radiol
  18. ECKSTEIN J, Skeries V, Pohler G, Babazade N, et al
    Multiparametric Cardiovascular MRI Assessment of Post-COVID Syndrome in Children in Comparison to Matched Healthy Individuals.
    Invest Radiol. 2024;59:472-478.
    PubMed         Abstract available


    J Infect
  19. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
    Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
    J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
    PubMed         Abstract available
  20. HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
    J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
    PubMed        


    J Med Virol
  21. FENG Y, Zhao X, Chen Z, Wu Y, et al
    Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021-2022.
    J Med Virol. 2024;96:e29664.
    PubMed         Abstract available
  22. ISHII T, Nawa N, Hosokawa S, Morio T, et al
    Exploring viral infections’ role in Kawasaki disease onset: A study during the COVID-19 pandemic.
    J Med Virol. 2024;96:e29660.
    PubMed         Abstract available
  23. ASHOKKUMAR S, Lim JS, Kaushik NK, Han I, et al
    Human coronavirus 229E inactivation on porous and nonporous materials using dielectric barrier discharge (DBD) plasma.
    J Med Virol. 2024;96:e29655.
    PubMed         Abstract available
  24. WU JY, Chen CC, Liu MY, Hsu WH, et al
    Clinical effectiveness of nirmatrelvir plus ritonavir on the short- and long-term outcome in high-risk children with COVID-19.
    J Med Virol. 2024;96:e29662.
    PubMed         Abstract available
  25. CHENG P, Zhai K, Han W, Zeng J, et al
    Characterizing the antigenic evolution of pandemic influenza A (H1N1) pdm09 from 2009 to 2023.
    J Med Virol. 2024;96:e29657.
    PubMed         Abstract available
  26. CHEN SY, Hsieh TYJ, Hung YM, Oh JW, et al
    Prior COVID-19 vaccination and reduced risk of cerebrovascular diseases among COVID-19 survivors.
    J Med Virol. 2024;96:e29648.
    PubMed         Abstract available
  27. RZYMSKI P, Zarebska-Michaluk D, Parczewski M, Genowska A, et al
    The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.
    J Med Virol. 2024;96:e29651.
    PubMed         Abstract available
  28. GRUBER CEM, Tucci FG, Giombini E, Mazzotta V, et al
    Molnupiravir increases SARS-CoV-2 genome diversity and complexity: A case-control cohort study.
    J Med Virol. 2024;96:e29642.
    PubMed         Abstract available


    J Virol
  29. ADAIR A, Tan LL, Feng J, Girkin J, et al
    Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection.
    J Virol. 2024 May 6:e0053124. doi: 10.1128/jvi.00531.
    PubMed         Abstract available
  30. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    PubMed         Abstract available


    JAMA
  31. HARRIS E
    National Academies Report: COVID-19 Vaccines Don’t Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    PubMed        
  32. ANDERER S
    Could “Empathetic Refutation” Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed        
  33. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed        
  34. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed        


    Lancet
  35. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed        


    Lancet Infect Dis
  36. WANG H, Wei Y, Hung CT, Lin G, et al
    Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study.
    Lancet Infect Dis. 2024 May 3:S1473-3099(24)00217.
    PubMed         Abstract available
  37. ARES-GOMEZ S, Mallah N, Santiago-Perez MI, Pardo-Seco J, et al
    Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
    Lancet Infect Dis. 2024 Apr 30:S1473-3099(24)00215.
    PubMed         Abstract available
  38. SORIANO V, Moreno-Torres V
    Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection.
    Lancet Infect Dis. 2024 May 3:S1473-3099(24)00258.
    PubMed        


    Nature
  39. DESAUTELS TA, Arrildt KT, Zemla AT, Lau EY, et al
    Computationally restoring the potency of a clinical antibody against Omicron.
    Nature. 2024 May 8. doi: 10.1038/s41586-024-07385.
    PubMed         Abstract available


    Science
  40. THORP HH
    Mr. Thorp goes to Washington.
    Science. 2024;384:601.
    PubMed         Abstract available
  41. COHEN J
    Virus gone wild.
    Science. 2024;384:615-617.
    PubMed         Abstract available


    Zhonghua Jie He He Hu Xi Za Zhi
  42. YANG LL, Huang LT, Ren SY, Ouyang RY, et al
    [COVID-19 in patients with Good syndrome: report of 4 cases and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:430-436.
    PubMed         Abstract available
  43. LIU MH, Sun YX, Li ZL, Zhang LJ, et al
    [Retrospective analysis of diagnosis and treatment of tuberculosis in designated medical institutions in China from 2017 to 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:437-443.
    PubMed         Abstract available
  44. GU SJ, Wen JL, Wang XY, Zhang LX, et al
    [Progress in the diagnose and treatment of pulmonary arterial thrombosis in situ].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:464-469.
    PubMed         Abstract available

#Influenza and other Respiratory Viruses Research #References (by AMEDEO, May 11 ’24)

  1. LIN X, Chen X, Chen Y, Xu P, et al
    Sleep initiation patterns and sleep quality among toddlers in the southeast of China: initial study results.
    BMC Pediatr. 2024;24:298.
    PubMed         Abstract available


    BMJ

  2. Seven days in medicine: 1-7 May 2024.
    BMJ. 2024;385:q1022.
    PubMed        
  3. MAHASE E
    Workforce and winter under Labour: Wes Streeting on his plan for the NHS and ending the strikes.
    BMJ. 2024;385:q992.
    PubMed        
  4. WONG G, Kelly M
    NHS funding for a secure future: naming the elephant in the room.
    BMJ. 2024;385:q1036.
    PubMed        
  5. NAKWEYA G
    Moderna’s decision to shelve vaccine plant in Kenya should encourage global south’s self-reliance, says global health adviser.
    BMJ. 2024;385:q1051.
    PubMed        
  6. MAFI A
    Doctors in training should be at the top of the workforce priority list.
    BMJ. 2024;385:q1045.
    PubMed        
  7. WATERS A
    LMC removes GP from committee amid row over attendance at meetings.
    BMJ. 2024;385:q1021.
    PubMed        
  8. LOOI MK
    Why WHO changed the definition of “airborne transmission” in the wake of the pandemic.
    BMJ. 2024;385:q985.
    PubMed        
  9. LYNN E
    April top picks: Hope springs eternal.
    BMJ. 2024;385:q1037.
    PubMed        


    Epidemiol Infect
  10. GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al
    Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study.
    Epidemiol Infect. 2024;152:e69.
    PubMed         Abstract available


    J Clin Microbiol
  11. SMY L, Ledeboer NA, Wood MG
    At-home testing for respiratory viruses: a minireview of the current landscape.
    J Clin Microbiol. 2024;62:e0031223.
    PubMed         Abstract available


    J Epidemiol Community Health
  12. YEUNG A, Wilkinson M, Bishop J, Taylor B, et al
    SARS-CoV-2 vaccine uptake and risks of severe COVID-19 disease among people prescribed opioid agonist therapy in Scotland.
    J Epidemiol Community Health. 2024;78:380-387.
    PubMed         Abstract available


    J Gen Virol
  13. KARA Y, Kizil MC, Iseri Nepesov M, Kacmaz E, et al
    Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic.
    J Gen Virol. 2024;105.
    PubMed         Abstract available


    J Immunol
  14. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    PubMed         Abstract available
  15. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    PubMed         Abstract available


    J Infect Dis
  16. HOY G, Stadlbauer D, Balmaseda A, Kuan G, et al
    Humoral correlates of protection against influenza A H3N2 virus infection.
    J Infect Dis. 2024 May 9:jiae258. doi: 10.1093.
    PubMed         Abstract available


    JAMA
  17. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed        
  18. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed        
  19. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed        
  20. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed        
  21. ANDERER S
    Could “Empathetic Refutation” Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed        


    Lancet
  22. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed        
  23. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    PubMed        


    Pediatrics
  24. MORO PL, Scheffey A, Gallego R, Jones JM, et al
    Incorrect Administration of Adult RSV Vaccines to Young Children.
    Pediatrics. 2024;153:e2024066174.
    PubMed        


    PLoS Comput Biol
  25. BOUMAN JA, Hauser A, Grimm SL, Wohlfender M, et al
    Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models.
    PLoS Comput Biol. 2024;20:e1011575.
    PubMed         Abstract available


    PLoS One
  26. SELVAVINAYAGAM TS, Viswanathan V, Ramalingam A, Kangusamy B, et al
    Prevalence of Noncommunicable Disease (NCDs) risk factors in Tamil Nadu: Tamil Nadu STEPS Survey (TN STEPS), 2020.
    PLoS One. 2024;19:e0298340.
    PubMed         Abstract available
  27. VOLTMER K, von Salisch M
    Longitudinal prediction of primary school children’s COVID-related future anxiety in the second year of the pandemic in Germany.
    PLoS One. 2024;19:e0302065.
    PubMed         Abstract available
  28. IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
    BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    PLoS One. 2024;19:e0302722.
    PubMed         Abstract available
  29. VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
    How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
    PLoS One. 2024;19:e0303043.
    PubMed         Abstract available
  30. MALKOWSKI OS, Townsend NP, Kelson MJ, Foster CEM, et al
    Socio-economic inequalities in the breadth of internet use before and during the COVID-19 pandemic among older adults in England.
    PLoS One. 2024;19:e0303061.
    PubMed         Abstract available
  31. AL MAQBALI M, Alsayed A, Hughes C, Hacker E, et al
    Stress, anxiety, depression and sleep disturbance among healthcare professional during the COVID-19 pandemic: An umbrella review of 72 meta-analyses.
    PLoS One. 2024;19:e0302597.
    PubMed         Abstract available
  32. OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
    COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
    PLoS One. 2024;19:e0303172.
    PubMed         Abstract available
  33. AGGARWAL S, Singh L, Alam U, Sharma S, et al
    COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    PLoS One. 2024;19:e0294480.
    PubMed         Abstract available
  34. LIU X, Xie CP
    Person-organization fit and job burnout of researchers during the COVID-19 pandemic: Heterogeneity in eleven countries.
    PLoS One. 2024;19:e0302296.
    PubMed         Abstract available
  35. NAPOLITANO JM, Srikanth S, Noorai RE, Wilson S, et al
    SARS-CoV-2 variant introduction following spring break travel and transmission mitigation strategies.
    PLoS One. 2024;19:e0301225.
    PubMed         Abstract available
  36. MEYER C, Crayton E, Wright A, Spyer M, et al
    Factors influencing uptake of protective behaviours by healthcare workers in England during the COVID-19 pandemic: A theory-based mixed-methods study.
    PLoS One. 2024;19:e0299823.
    PubMed         Abstract available
  37. GALIERO R, Loffredo G, Simeon V, Caturano A, et al
    Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy.
    PLoS One. 2024;19:e0296495.
    PubMed         Abstract available
  38. PASAT Z, Sinn CJ, Rahman B, Gayowsky A, et al
    The relationship between patient experience and real-world digital health access in primary care: A population-based cross-sectional study.
    PLoS One. 2024;19:e0299005.
    PubMed         Abstract available
  39. SCOGLIO AAJ, Nishimi K, Choi KW, Koenen KC, et al
    Prior resilience to trauma & coping during the COVID-19 pandemic.
    PLoS One. 2024;19:e0297169.
    PubMed         Abstract available
  40. GROSS RS, Thaweethai T, Rosenzweig EB, Chan J, et al
    Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
    PLoS One. 2024;19:e0285635.
    PubMed         Abstract available
  41. ROCA C, Asturizaga A, Villca N, Cabrera R, et al
    Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients.
    PLoS One. 2024;19:e0283037.
    PubMed         Abstract available
  42. FERNANDEZ D, Perez-Alvarez N, Molist G
    COVID-19 patient profiles over four waves in Barcelona metropolitan area: A clustering approach.
    PLoS One. 2024;19:e0302461.
    PubMed         Abstract available
  43. DE WITTE D, Abad AA, Neyens T, Verbeke G, et al
    A joint penalized spline smoothing model for the number of positive and negative COVID-19 tests.
    PLoS One. 2024;19:e0303254.
    PubMed         Abstract available
  44. AALOKKEN TM, Ashraf H, Einvik G, Lerum TV, et al
    CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study.
    PLoS One. 2024;19:e0302896.
    PubMed         Abstract available
  45. GNADE CM, Avery CC, Yang Z, Pickett CM, et al
    Social media trends in obstetrics and gynecology residency programs on Instagram and X (Twitter).
    PLoS One. 2024;19:e0296930.
    PubMed         Abstract available
  46. CARDENAS-CALLE M, Patino L, Pernia B, Erazo R, et al
    Detection of thermotolerant coliforms and SARS-CoV-2 RNA in sewage and recreational waters in the Ecuadorian coast: A call for improving water quality regulation.
    PLoS One. 2024;19:e0302000.
    PubMed         Abstract available
  47. KIM S, Lilani A, Redemptus C, Campana K, et al
    A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    PLoS One. 2024;19:e0300206.
    PubMed         Abstract available
  48. WEBB EJD, Conaghan PG, Henderson M, Hulme C, et al
    Long-term health conditions and UK labour market outcomes during the COVID-19 pandemic.
    PLoS One. 2024;19:e0302746.
    PubMed         Abstract available
  49. DU W, Zhao L, Wu R, Huang B, et al
    Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2.
    PLoS One. 2024;19:e0299696.
    PubMed         Abstract available
  50. ELIAS TP, Gebreamlak TW, Gebremeskel TT, Adde BL, et al
    Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
    PLoS One. 2024;19:e0298409.
    PubMed         Abstract available
  51. PALL T, Abroi A, Avi R, Niglas H, et al
    SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
    PLoS One. 2024;19:e0303176.
    PubMed         Abstract available
  52. RAMOS A, Martins S, Marinho AS, Norton P, et al
    Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
    PLoS One. 2024;19:e0303244.
    PubMed         Abstract available
  53. TO T, Zhu J, Terebessy E, Borkhoff CM, et al
    Mode of delivery and birth outcomes before and during COVID-19 -A population-based study in Ontario, Canada.
    PLoS One. 2024;19:e0303175.
    PubMed         Abstract available
  54. VINDEIRINHO JM, Oliveira R, Pinho E, Guiomar R, et al
    The potential of tailed amplicons for SARS-CoV-2 detection in Nucleic Acid Lateral Flow Assays.
    PLoS One. 2024;19:e0301234.
    PubMed         Abstract available
  55. MARTELL M, Terry N, Sengupta R, Salazar C, et al
    Open-source data pipeline for street-view images: A case study on community mobility during COVID-19 pandemic.
    PLoS One. 2024;19:e0303180.
    PubMed         Abstract available
  56. BAUTISTA-ARREDONDO LF, Munoz-Rocha TV, Figueroa JL, Tellez-Rojo MM, et al
    A surge in food insecurity during the COVID-19 pandemic in a cohort in Mexico City.
    PLoS One. 2024;19:e0297694.
    PubMed         Abstract available
  57. YASOPA O, Homkham N, Chompook P
    Factors affecting the number of influenza patients before and during COVID-19 pandemic, Thailand.
    PLoS One. 2024;19:e0303382.
    PubMed         Abstract available
  58. FERDOUS MZ, Islam MS, Kundu LR, Islam US, et al
    Patterns of eating behaviors, physical activity, and lifestyle modifications among Bangladeshi adolescents during the COVID-19 pandemic.
    PLoS One. 2024;19:e0302571.
    PubMed         Abstract available
  59. CHEN N, Wang R, Zhu W, Hao X, et al
    Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.
    PLoS One. 2024;19:e0302865.
    PubMed         Abstract available
  60. KERN M, Glatz T, Mall MA, Seybold J, et al
    Health-related quality of life and impact of socioeconomic status among primary and secondary school students after the third COVID-19 wave in Berlin, Germany.
    PLoS One. 2024;19:e0302995.
    PubMed         Abstract available
  61. NOUR D, Ismail MB, Osman M, Rafei R, et al
    Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
    PLoS One. 2024;19:e0302579.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A
  62. MORALES M, Yang MY, Goddard WA 3rd, Gray HB, et al
    Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1.
    Proc Natl Acad Sci U S A. 2024;121:e2402653121.
    PubMed         Abstract available


    Vaccine
  63. WALLACE M, Rosenblum HG, Moulia DL, Broder KR, et al
    A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
    Vaccine. 2023 Jul 30:S0264-410X(23)00868-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
  64. EHRLICH KB, Lyle SM, Corallo KL, Lavner JA, et al
    Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults.
    Vaccine. 2024 May 2:S0264-410X(24)00505-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  65. BENEDICT KPOZEHOUEN E, Macintyre CR, Tan TC
    Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Vaccine. 2024 May 3:S0264-410X(24)00445-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  66. MAUREL M, Mazagatos C, Goerlitz L, Oroszi B, et al
    Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Vaccine. 2024 May 3:S0264-410X(24)00497-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  67. SHI XC, Gruber JF, Ondari M, Lloyd PC, et al
    Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older.
    Vaccine. 2024 May 3:S0264-410X(24)00478-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  68. KIM J, Chang J
    Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.
    Vaccine. 2024 May 6:S0264-410X(24)00481-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
  69. KIM DH, Lee SH, Kim J, Lee J, et al
    Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
    Vaccine. 2024 May 8:S0264-410X(24)00527-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


    Virus Res
  70. WU CC, Tam EH, Shih YY, Lin YR, et al
    Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function.
    Virus Res. 2024 May 6:199387. doi: 10.1016/j.virusres.2024.199387.
    PubMed         Abstract available